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ABSTRACT 
 
Analogous to the extracellular matrix (ECM) of natural tissues, properties of a 
tissue engineering scaffold direct cell behavior and thus regenerated tissue properties. 
These include both physical properties (e.g. morphology and modulus) and chemical 
properties (e.g. hydrophobicity, hydration and bioactivity).  Notably, recent studies 
suggest that scaffold properties (e.g. modulus) may be as potent as growth factors in 
terms of directing stem cell fate. Thus, 3D scaffolds possessing specific properties 
modified for optimal cell regeneration have the potential to regenerate native-like 
tissues.  Photopolymerizable poly(ethylene glycol) diacrylate (PEG-DA)-based 
hydrogels are frequently used as scaffolds for tissue engineering. They are ideal for 
controlled studies of cell-material interactions due to their poor protein adsorption in the 
absence of adhesive ligands thereby making them “biological blank slates”. However, 
their range of physical and chemical properties is limited. Thus, hydrogel scaffolds 
which maintain the benefits of PEG-DA but possess a broader set of tunable properties 
would allow the establishment of predictive relationships between scaffold properties, 
cell behavior and regenerated tissue properties.  
Towards this goal, this work describes a series of unique hybrid inorganic-
organic hydrogel scaffolds prepared using different solvents and also in the form of 
continuous gradients. Properties relevant to tissue regeneration were investigated 
including: swelling, morphology, modulus, degradation rates, bioactivity, 
cytocompatibility, and protein adhesion. These scaffolds were based on the 
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incorporation of hydrophobic, bioactive and osteoinductive methacrylated star 
polydimethylsiloxane (PDMSstar-MA) [“inorganic component”] into hydrophilic PEG-
DA [“organic component”]. The following parameters were varied: molecular weight 
(Mn) of PEG-DA (Mn = 3k & 6k g/mol) and PDMSstar-MA (Mn = 1.8k, 7k, 14k), ratio of 
PDMSstar-MA to PEG-DA (0:100 to 20:80), total macromer concentration (5 to 20 wt%) 
and utilizing either water or dichloromethane (DCM) fabrication solvent. The use of 
DCM produced solvent induced phase separation (SIPS) resulting in scaffolds with 
macroporous morphologies, enhanced modulus and a more homogenous distribution of 
the PDMSstar-MA component throughout. These hybrid hydrogel scaffolds were 
prepared in the form of continuous gradients such that a single scaffold contains spatially 
varied chemical and physical properties. Thus, cell-material interaction studies may be 
conducted more rapidly at different “zones” defined along the gradient. These gradients 
are also expected to benefit the regeneration of the osteochondral interface, an interfacial 
tissue that gradually transitions in tissue type. The final aspect of this work was focused 
on enhancing the osteogenic potential of PDMS via functionalization with amine and 
phosphonate. Both amine and phosphonate moieties have demonstrated bioactivity. 
Thus, it was expected that these properties will be enhanced for amine and phosphonate 
functionalized PDMS. The subsequent incorporation of these PDMS-based macromers 
into the previously described PEG-DA scaffold system is expected to be valuable for 
osteochondral tissue regeneration.  
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CHAPTER I  
INTRODUCTION  
1.1. Background 
1.1.1. Osteochondral Defects 
Osteochondral Defects (OCDs) are areas of joint damage affecting both the 
cartilage and underlying subchondral bone (Figure 1.1) [1, 2].  These defects, which can 
result from injury and/or disease often lead to excruciating pain and an advanced form of 
osteoarthritis [1, 3-6].  
 
 
 
 
 
 
 
 
 
 
 
 
A common example of an OCD resulting from injury is “post-traumatic 
osteoarthritis” which affects approximately 5.6 million people in the United States 
Figure 1.1. Osteochondral defects are characterized by a loss of bone and cartilage tissue as well as the 
transition between these tissues. These defects (shown here in the medial femoral condyle) are both 
painful and progressive. 
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across all age groups [7-14].  OCDs in younger patients present an exceptionally 
difficult clinical problem due to the undesirable utilization of treatments such as joint 
replacement or joint fusion which limit activity [15, 16]. This is also the case for OCDs 
resulting from  osteochondral dissecans (i.e. disease) and sickle cell disease,[17] where 
the majority of those affected are physically active adolescents [18]. Osteochondral 
dissecans is a disease resulting in the deterioration of articular cartilage and thus a loss of 
lubrication and support in the joint. Cartilage is avascular and has poor intrinsic healing 
capabilities; therefore, loss of the cartilage-bone interface within a joint will lead to 
further bone deterioration, agonizing pain, and potentially osteoarthritis [19, 20].  Noting 
the prevalence of OCDs, the inability of cartilage to naturally repair, and the problems 
associated with long-term presence of these defects, the definite need for an 
osteochondral defect replacement or treatment option can be seen. 
1.1.2. Current Treatments of OCDs 
Smaller OCDs across articular cartilage-bone interface are generally treated by 
arthroscopic drilling, abrasion, or microfracturing [20, 21]. However, these mainly 
produce fibrocartilage at the defect site which is biomechanically inferior to articular 
cartilage and thus deteriorates over time [20, 22, 23]. Much research has focused on new 
techniques that fill defects with tissues that more closely mimic native osteochondral 
tissue. These treatments include autograft procedures,[24-27] such as the osteochondral 
autograft transfer system (OATS), where osteochondral cylindrical plugs are removed 
from a joint area of minor load and press-fitted into pre-drilled holes at the defect site 
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[28]. Another common autograft treatment involves periosteal/perichondrial 
transplantation to full-thickness defects [29]. However, autografts are limited in supply 
and often result in severe donor site morbidity, as well as graft delamination and 
endochondral ossification. The alternative use of allografts often results in failure due to 
infection and rejection [30-33]. Another treatment option is joint fusion, where pieces of 
bone or metal implants are used to stimulate fusion of the bones. However, this limits 
motion and is prone to infection and ultimately deterioration [34]. “Autologous 
chondrocyte transfer” (ACT) is another biological approach based on the implantation of 
a suspension of cultured autologous chondrocytes beneath a tightly sealed periosteal flap 
[35-37]. However, the use of ACT carries a number of limitations, essentially related to 
the complexity of the surgical procedure and the biological response of the periosteum 
[38-40]. Due to the limitations associated with the aforementioned treatments, OCDs 
ultimately necessitate replacement of the entire joint.  Annually in the US, >500,000 
total knee replacements (TKRs) are performed at a cost of >$11 billion [41, 42]. Despite 
it‟s prevelence, TKR is generally not effective as it results in chronic knee 
pain and stiffness, bleeding into the knee joint, and nerve damage and is also quite costly 
[42-47].  In general, current biological and replacement treatments show limited success 
as they do not consistently result in long-term repair.  
1.1.3. Tissue Engineering of OCDs 
Tissue engineering is an alternative approach for OCD repair that may avoid 
many of the limitations associated with current treatments [48]. A three-dimensional 
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scaffold is utilized to create an environment in which living cells can proliferate, 
differentiate, and ultimately produce a new extracellular matrix (ECM) [49]. 
Specifically, it has been shown that through defined scaffold cues, MSCs are able to 
acquire characteristics of cells derived from embryonic mesoderm, including osteoblasts 
(bone cells) and chondrocytes (cartilage cells) [50-52]. Regeneration of interfacial 
tissues is particularly complex. Conventionally, regeneration of the osteochondral 
interface has been attempted by connecting (via fibrin glue, sutures, or press fitting) two 
compositionally homogenous scaffolds designed to individually promote either bone or 
cartilage tissue growth [53-58]. However, the resulting individual tissues are not 
mechanically representative of the respective native tissues [59]. Finally, the inability of 
the scaffold to securely bind to the defect site results in a lack of cell infiltration and 
ultimate graft delamination [60, 61]. Thus, an improved approach to regenerate the 
osteochondral interface in which the engineered bone and cartilage tissues are joined via 
an interface characterized by a gradual transition in properties and interpenetration is 
necessary.   
Natural and synthetic polymers have been used to construct scaffolds for tissue 
engineering [62-64]. One major advantage that synthetic polymers have over natural 
polymers is their ability to offer superior control and range of chemical and physical 
properties [65-67]. The use of synthetic hydrogels as tissue engineering scaffolds has 
been the subject of extensive research [67-69]. Hydrogels are highly hydrated polymer 
networks consisting primarily of hydrophilic polymers which are crosslinked through 
chemical bonds or physical interactions [70-73]. Hydrogels are ideal for use as tissue 
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engineering scaffolds due to their superior biocompatibility which minimizes 
inflammation, thrombosis, and tissue damage, as well as their high diffusivity and 
elasticity which is analogous to many tissues [67-69]. It has been found that non-specific 
chemical and physical properties of scaffolds directly influence the properties (e.g. 
mechanical) of the regenerated tissue [74]. Altering the chemical nature of the scaffold, 
(e.g. bioactivity, chemical functionality, and hydrophilicity [75, 76]) as well as physical 
properties (e.g. scaffold morphology [77-84] and modulus [74, 85-87]) is known to 
influence cell behavior. Thus, a hydrogel scaffold that guides cellular behavior by nature 
of its physical and chemical properties could be designed to produce a gradual transition 
in regenerative tissue properties as an effective tool for tissue engineering the 
osteochondral interface.  
1.2. Approach 
1.2.1. Overview 
The two main obstacles hindering the regeneration of a native-like osteochondral 
interface are (1) deficient knowledge of the optimal scaffold properties which 
independently promote the regeneration of native-like bone and cartilage tissue and (2) 
the lack of a gradual transition and integration between these tissues. It is hypothesized 
that these challenges will be addressed by the inorganic-organic hydrogel scaffolds 
reported herein.  
Herein, a series of “hybrid” 3D hydrogel scaffolds were prepared based on 
combining an inorganic and organic macromer and using both aqueous and organic 
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fabrication solvents. Scaffold physical and chemical properties were controlled by 
altering molecular weight (Mn) of PEG-DA (Mn = 3k & 6k g/mol) and PDMSstar-MA 
(Mn = 1.8k, 7k, 14k), ratio of PDMSstar-MA to PEG-DA (0:100 to 20:80), total 
macromer concentration (5 to 20 wt%) and utilizing either water (DI-H2O) or 
dichloromethane (DCM) as the fabrication solvent. The subsequent preparation of these 
hybrid hydrogel scaffolds in the form of continuous gradients will allow for rapid 
assessment of cell-material interactions and is also expected to benefit the regeneration 
of interfacial tissues which gradually transition between tissue types (Figure 1.2). The 
final aspect of this work was focused on the functionalization of a PDMS macromer with 
phosphonate and amine groups towards enhancing PEG-DA scaffold bioactivity and 
osteoinductivity.  
 
 
 
 
 
 
 
 
 
 
Regeneration of 
Interfacial Tissues
Gradually 
transition 
types,
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3D Polymer 
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material interactions
Peristaltic Pump
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M
a
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Gradually 
Transition 
Properties
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Cartilage
Transition
Figure 1.2. Scaffolds fabricated herein contain a broad range of spatially varied chemical and physical 
properties and thus, will be beneficial towards the rapid assessment of cell-material interactions and the 
ultimate regeneration of interfacial tissues. 
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1.2.2. PEG-DA Hydrogels as Tissue Engineering Scaffolds 
The resistance to protein and cell adhesion of PEG-DA hydrogels in the absence 
of precisely introduced adhesive ligands makes them particularly useful to study cell-
material interactions [88-92]. However, their range of physical, as well as chemical 
properties is limited, thus restricting their utility for such studies. Accordingly, the aim 
of the research herein is the fabrication of a series of hydrogel scaffolds which maintain 
the benefits of PEG-DA but possess a broader range of tunable properties. In addition, a 
method to gradually transition these properties within a single hydrogel scaffold is 
presented. These gradient scaffolds will allow for a more rapid assessment of the 
relationship between scaffold properties, cell behavior and regenerated tissue properties. 
The ability to gradually transition the properties of a single scaffold is also expected to 
benefit the regeneration of the osteochondral interface, an interfacial tissue that 
gradually transitions in tissue type.  
1.2.3. Modification of PEG-DA Hydrogel Properties via Solvent Induced Phase 
Separation (SIPS) 
An organic fabrication solvent was employed as a tool to extend the physical 
properties of PEG-DA hydrogels [93]. Using a solvent-based precursor solution in 
substitution of the conventional aqueous precursor solution has been reported to promote 
a phase separation of the growing polymer chains during photocure. This results in 
polymer rich networks surrounding polymer lean domains (i.e. pores) [93-95] and thus a 
macroporous morphologies. Macroporous hydrogels have shown particular utility to 
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enhance tissue engineering outcomes [79, 82, 84, 96, 97]. Furthermore, increased pore 
size has been shown to enhance degradation rates [98].  Thus, pore size can be used to 
design scaffolds that ideally degrade at a rate corresponding with tissue regeneration 
[99]. Thus, PEG-DA hydrogels prepared via SIPS exhibited macroporous morphologies 
[93, 100]. In addition, SIPS resulted in increased modulus but did not necessarily effect 
total swelling compared to analogous water-fabricated hydrogels. Thus, within this 
library of scaffolds pairs of hydrogels were identified whose modulus and hydration or 
morphology and hydration were uncoupled.  Such scaffolds would permit independent 
study of these properties on cell behavior. Furthermore, the tunable porosity, modulus 
and degradation rates of these scaffolds are expected to enhance their utility as 
environments for tissue regeneration as well as provide a means to study these effects on 
cell behavior.  
1.2.4. Modification of PEG-DA Hydrogel Properties via Incorporation of Methacrylated 
Star Poly(dimethyl siloxane) (PDMSstar-MA)via SIPS 
Inorganic, hydrophobic PDMSstar-MA was incorporated into organic PEG-DA 
hydrogel scaffolds to extend the range of physical properties and chemical properties 
[100]. This was expected given the unique properties of PDMSstar-MA: (1) low glass 
transition temperature (Tg = -127 ˚C), (2) hydrophobicity and (3)  inorganic nature.  
When incorporated into a PEG-DA hydrogel, the flexibility of low Tg PDMSstar-
MA is expected to alter mechanical properties. The hydrophobicity of PDMSstar-MA 
renders it insoluble in H2O but soluble in DCM such that fabrication via SIPS alters its 
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distribution throughout the PEG-DA matrix [100, 101]. In addition, scaffold 
hydrophobicity has also been shown to influence osteogenic differentiation [102-104]. 
Previous studies have demonstrated that the incorporation of inorganic silicon-
containing materials into organic scaffolds enhances their bioactivity [105-107]. Munoz-
Pinto et al. demonstrated that PDMSstar-PEG scaffolds guide mesenchymal stem cells 
toward osteogenic differentiation with increased amounts of the bone cell marker, 
osteocalcin being observed with increased amounts of PDMS star-MA [108].
 Thus, 
PDMSstar-PEG hydrogels prepared via SIPS can be used to alter scaffold physical and 
chemical properties including modulus and osteoinductivity. 
1.2.5. Fabrication of PDMSstar-PEG Hydrogels as Continuous Gradients 
These hybrid PDMSstar-PEG hydrogels were then fabricated in the form of 
continuous gradients (such that a single scaffold contains spatially varied chemical and 
physical properties) in both DI-H2O and DCM (Figure 1.2) [109]. Three-dimensional 
continuous gradients have been reported [110-113]. Recently, Chatterjee and co-workers 
used a gradient maker to produce continuous gradient hydrogel scaffolds based on an 
organic macromer [poly(ethylene glycol)-diacrylate, PEG-DA] and an aqueous 
fabrication solvent [114]. In this study, this method has been applied to prepare “hybrid” 
continuous gradient hydrogel scaffolds based on combining an inorganic and organic 
macromer and using both aqueous and organic fabrication solvents. Their rapid 
production and achievable range of properties not only allow for rapid screening of cell-
material interactions, but would also prove useful towards the regeneration of interfacial 
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tissues which require scaffolds comprised of spatially organized material compositions 
[114, 115]. Given the bioactivity and osteoinductivity of PDMSstar-MA, these hybrid 
scaffolds are of particular interest for bone and osteochondral tissue engineering. 
1.2.6. Chemical Functionalization of PDMS towards Enhanced Bioactivity and 
Ostoeinductivity 
The final aspect of this work is focused on further enhancing the bioactivity and 
osteoinductivity of PDMS macromer via functionalization with amine and phosphonate 
groups. Well-defined (2D) models have been used to study the effects of amine and 
phosphonate on cell behavior [116-119]. Keselowsky et al. demonstrated that surfaces 
grafted with amine groups up-regulated osteoblast-specific gene expression, alkaline 
phosphatase enzymatic activity, and matrix mineralization [117]. The positive charge on 
these functional groups at neutral pH may explain this phenomenon [117]. Increasing 
phosphonate content of graft copolymers on the surface of biomaterials increased 
osteoblast-like cell adhesion and proliferation [120]. Also, the addition of pendant 
phosphorous-containing groups to polymers has shown to result in more complete 
mineralization and at a faster rate in vitro [121, 122]. Phosphorous-based scaffolds are of 
particular interest for bone tissue regeneration given the ideal osteoinductive 
environment they are able to provide [123-125]. Saltzman et al. found that the adhesion 
and growth of osteoblast-like cells within acrylamide gels increased with increasing 
phosphonate content [123]. While, Anseth et al. incorporated pendant phosphate groups 
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into PEG hydrogels and found that this increased both the rate and degree of 
mineralization within the hydrogel even in the absence of hMSCs [126].  
Thus, it was hypothesized that amine and phosphonate functionalized PDMS will 
exhibit enhanced bioactivity and osteoinductivity. The subsequent incorporation of these 
PDMS-based macromers into the previously described PEG-DA scaffold system is 
expected to provide a method to study their effect on cell behavior in a 3D environment. 
These scaffolds are also anticipated to be valuable for osteochondral tissue regeneration.  
1.3. Innovation 
1.3.1. Manipulation of PEG-DA Hydrogel Properties via SIPs and PDMSstar  
Grunlan and co-workers were the first to incorporate PDMSstar-MA into PEG-DA 
hydrogel scaffolds [127]. These were limited to those prepared with an aqueous 
precursor solution and prepared as “single composition” hydrogels. Munoz-Pinto et al. 
demonstrated that these scaffolds guide MSCs toward osteogenic differentiation with 
increased amounts of the bone cell marker, osteocalcin being observed with increased 
amounts of PDMS star-MA [108]. Unique to the proposed research is the use of SIPS to 
fabricate PEG and PDMSstar-PEG hydrogel scaffolds with macroporous morphologies 
and controlled distribution of the inorganic component. Until now, SIPS has only been 
utilized to prepare macroporous poly(N-isopropylacrylamide) (PNIPAAm) hydrogels 
[94, 95]. Macroporous hydrogels have shown particular utility to enhance tissue 
engineering outcomes as they allow for cell ingrowth and enhanced degradation rates 
[79, 82, 84, 96-98]. However, conventional PEG-DA hydrogels (i.e. fabricated by the 
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photopolymerization of aqueous precursor solutions) are generally limited in their size 
and amount of native pores (i.e. approximately 5–10 μm pore size for a Mn = 3.4k to 
6k),[128] whereas a pore size of 100-250 μm is considered ideal for bone tissue 
regeneration [129, 130]. In addition to producing macropores, SIPS alters the 
distribution of the inorganic, hydrophobic PDMSstar-MA due to its improved solubility in 
DCM versus water. As PDMSstar-MA is bioactive and osteoinductive, its controlled 
redistribution within the PEG-DA matrix is significant. The homogeneous redistribution 
is also expected to alter the way in which PDMSstar-MA impacts scaffold physical 
properties due to the distinct properties it possesses (i.e. low Tg, hydrophobic, inorganic). 
1.3.2. Fabrication of PDMSstar-PEG Scaffolds as Continuous Gradients 
Novel gradient hydrogel scaffolds were subsequently fabricated based on the 
wt% ratio of the PDMSstar-MA to PEG-DA macromer, the total wt% concentration of 
macromer in the precursor solution (water or DCM), and the molecular weight (Mn) of 
both PEG-DA and PDMSstar-MA. A previously reported continuous gradient making 
strategy was utilized to rapidly prepare scaffolds with gradually transitioning chemical 
and physical properties that will be subsequently characterized [114]. The approach 
presented herein offers a method for the systematic and rapid examination of scaffold-
mediated MSC response over a broad range of properties, as well as, a method for the 
regeneration of a native-like osteochondral interface.  
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1.3.3. Phosphonate and Amine Functionalized PDMS-MA 
Much research has revealed the osteoinductivity and/or bioactivity of silicon 
[102-104], phosphonates [116, 121, 125] and amines [117, 118]. Herein, amine 
functionalized PDMS macromer were prepared. Also, a rational and protocol were given 
for the synthesis of phosphonate functionalized PDMS. Their subsequent methacrylation 
will allow for incorporation into PEG-DA hydrogel scaffolds via photo-crosslinking. It 
is expected that these novel macromers combined with previously described fabrication 
processes (i.e. SIPS and continuous gradients) will provide a platform for the rapid 
assessment of a broad range of properties. These studies are anticipated to result in the 
establishment of an ideal environment for bone, cartilage, and bone – cartilage 
interfacial tissue regeneration.  
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CHAPTER II  
TUNING PEG-DA HYDROGEL PROPERTIES VIA SOLVENT-INDUCED PHASE 
SEPARATION (SIPS)* 
2.1. Overview 
Poly(ethylene glycol) diacrylate (PEG-DA) hydrogels are widely utilized to 
probe cell-material interactions and ultimately for a material-guided approach to tissue 
regeneration. In this study, PEG-DA hydrogels were fabricated via solvent-induced 
phase separaration (SIPS) to obtain hydrogels with a broader range of tunable physical 
properties including morphology (i.e. porosity), swelling and modulus (G„) (Figure 2.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Reprinted with permission from “Tuning PEG-DA hydrogel properties via solvent-induced phase separation (SIPS)” 
by Bailey BM, Hui V, Fei R, Grunlan MA, 2011. J Mater Chem, 21, 18776-82, Copyright [2011] by The Royal 
Society of Chemistry. http://pubs.rsc.org/en/content/articlelanding/2011/JM/c1jm13943f  
DCM precursor 
solution
Solvent-induced 
phase separation 
(SIPS)
1.Photocure
2.Dry
3.Hydrate
Macroscopic image 
of SIPS fabricated 
hydrogel
SEM image of SIPS 
fabricated hydrogel
Figure 2.1. Reported hydrogel fabrication via SIPS and resulting enhanced porous structure. 
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In contrast to conventional PEG-DA hydrogels prepared from an aqueous precursor 
solution, the reported SIPS protocol utilized a dichloromethane (DCM) precursor 
solution which was sequentially photopolymerized, dried and hydrated.  Physical 
properties were further tailored by varying the PEG-DA wt% concentration (5 wt% - 25 
wt%) and Mn (3.4k and 6k g/mol). SIPS produced PEG-DA hydrogels with a 
macroporous morphology as well as increased G„ values versus the corresponding 
conventional PEG-DA hydrogels. Notably, since the total swelling was not significantly 
changed versus the corresponding conventional PEG-DA hydrogel, pairs or series of 
hydrogels represent scaffolds in which morphology and hydration or G„ and hydration 
are uncoupled.  In addition, PEG-DA hydrogels prepared via SIPS exhibted enhanced 
degradation rates.  
2.2. Introduction 
As with the extracellular matrix (ECM) in natural tissues, the physical properties 
of tissue engineering scaffolds mediate cell behavior including regeneration [131-135]. 
Most notable are scaffold morphology (e.g. porosity) [77, 78, 81, 136-139] and modulus 
[74, 86, 87, 140]. Thus, regeneration of tissues which closely resemble native tissues 
may be accomplished through a material property-guided approach. Towards this goal, 
scaffolds whose physical properties can be precisely tuned over a broad range are 
essential. 
Poly(ethylene glycol) diacrylate (PEG-DA) hydrogels have been widely utilized 
as scaffolds for the regeneration of diverse tissues [90, 91, 98, 141-144]. They are 
 16 
 
particularly useful to probe cell-material interactions due to their resistance to protein 
and cell adhesion in the absence of the controlled introduction of adhesive ligands [88-
92]. The limited range of physical properties which may be obtained for PEG-DA 
hydrogels restricts their utility to study material-guided cell behavior. For instance, 
hydrogel mechanical properties may be tuned over a limited range by altering the weight 
% (wt%) concentration of PEG-DA in the precursor solution or the crosslink density as 
determined by PEG-DA number average molecular weight (Mn) [98, 145]. However, 
these changes simultaneously alter swelling behavior and so limit the ability to uncouple 
modulus and swelling and thus the impact of each on the cellular response [146]. 
Hydrogel scaffold morphology including porosity is also known to influence cell 
behavior [77, 147-150]. Macroporous hydrogels have shown particular utility to enhance 
tissue engineering outcomes [79, 97, 151]. Furthermore, increased pore size has been 
shown to be useful to enhance degradation rates [82, 152]. In order to increase their pore 
size range, several strategies have been used to produce PEG-DA hydrogels with 
macroporous morphologies, including: salt leaching [153, 154], cryogelation [155, 156], 
and gas foaming [157]. However, each method is associated with specific limitations 
such as difficulty leaching poragens (salt leaching), high temperatures or low pressures 
(gas foaming), and extremely low temperatures (cryogelation) [64, 158].  
To successfully produce functional tissues, it is highly desirable that the scaffold 
degrade at a rate which parallels regeneration [64, 67, 99]. Because of the stability of 
ether bonds and limited number of hydrolytically unstable ester crosslinks, PEG-DA 
hydrogels do not readily degrade under physiological conditions [159]. A variety of 
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synthetic strategies have been reported to enhance degradation of PEG-DA hydrogels, 
including incorporation of polyester segments [160-162], crosslinking to form labile 
bonds [163-165] and introduction of enzymatically unstable peptides [89, 166]. 
However, these alter the scaffold chemistry which is known to illicit changes in cell 
behavior [76, 167, 168].  
Solvent-induced phase separation (SIPS) has been utilized to prepare 
macroporous poly(N-isopropylacrylamide) (PNIPAAm) hydrogels [94, 95]. During 
SIPS, a solvent system is utilized which promotes phase separation of the growing 
polymer chain and network during cure. In this study, PEG-DA hydrogels were formed 
via SIPS by photocuring dichloromethane (DCM) precursor solutions rather than 
aqueous precursor solutions as is used to formed conventional PEG-DA hydrogels. 
Precursor solutions were formed with DCM at various wt% concentrations (5 wt% - 25 
wt%) and Mn‟s (3.4k and 6k g/mol) of PEG-DA and subsequently dried and hydrated. 
These concentrations and Mn‟s represent those typically utilized to prepare PEG-DA 
scaffolds for tissue engineering studies. The resulting macroporous morphology, 
swelling behavior, modulus, and degradation behavior was related to composition and 
compared to analogous conventional PEG-DA hydrogels fabricated from aqueous 
precursor solutions.  
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2.3. Materials and Methods 
2.3.1. Materials 
Allyl methacrylate, acryloyl chloride, triflic acid, 2,2-dimethyl-2-phenyl-
acetophenone (DMAP), 1-vinyl-2-pyrrolidinone (NVP), triethylamine (Et3N), MgSO4, 
K2CO3, hexamethyldisilazane (HMDS) and solvents were obtained from Sigma Aldrich. 
HPLC grade toluene and CH2Cl2 and NMR grade CDCl3 were dried over 4Å molecular 
sieves. Poly(ethylene glycol) (PEG) [PEG-6000; MW = 5000-7000 g/mol and PEG-
3400; MW = 3000-3700 g/mol per manufacturer‟s specifications] were obtained from 
BioChemika. The precise Mn‟s of PEG-3400 (3393 g/mol) and PEG-6000 (6143 g/mol) 
were back-calculated from 1H NMR end-group analysis of the corresponding diacrylated 
products.   
2.3.2. PEG-DA Synthesis 
PEG-DA (3.4k g/mol or 6k g/mol) were prepared as previously reported [127]. 
PEG-3400 (23.5 g, 7.0 mmol), Et3N (1.95 mL, 14.0 mmol) and acryloyl chloride (2.27 
mL, 28.0 mmol) were reacted to obtain PEG-DA (15.2 g, 63% yield). 1H NMR (δ, ppm): 
3.62 (s, 297H, -OCH2CH2), 5.81 (dd, 2H, J = 10.5 and 1.2 Hz, -CH=CH2), 6.13 (dd, 2H, 
J = 17.4 and 10.5 Hz, -CH=CH2), 6.40 (dd, 2H, J = 17.3 and 1.5 Hz, -CH=CH2). By 
1H 
NMR end-group analysis, Mn of PEG-DA (3.4k g/mol) was determined to be 3393 g/mol 
(∼3400 g/mol). PEG-6000 (24 g, 4.0 mmol), Et3N (1.12 mL, 8.0 mmol) and acryloyl 
chloride (1.30 mL, 16.0 mmol) were reacted to obtain PEG-DA (31 g, 63% yield). 1H 
NMR (δ, ppm): 3.61 (s, 547H, -OCH2CH2), 5.81 (dd, 2H, J = 10.4 and 1.5 Hz, -
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CH=CH2), 6.13 (dd, 2H, J = 16.8 and 10.5 Hz, -CH=CH2), 6.40 (dd, 2H, J = 17.3 and 
1.5 Hz, CH=CH2). By 
1H NMR end-group analysis, Mn of PEG-DA (6k g/mol) was 
determined to be 6143 g/mol (∼6000 g/mol). 
2.3.3. NMR 
 1H NMR spectra were obtained on a Mercury 300 300 MHz spectrometer 
operating in the Fourier transform mode. Five percent (w/v) CDCl3 solutions were used 
to obtain spectra. Residual CHCl3 served as an internal standard.   
2.3.4. Hydrogel Preparation 
PEG-DA hydrogels formed via SIPS were prepared from DCM-based precursor 
solutions whereas conventional PEG-DA hydrogels were prepared from aqueous 
precursor solutions. Precursor solutions were prepared at concentrations of 5, 10, 15, 20, 
and 25 wt% PEG-DA (Mn = 3.4k or 6k g/mol) in DCM or deionized (DI) water. 10 L 
of photoinitiator solution (30 wt% solution of DMAP in NVP) was added per one mL of 
the precursor solution. Solutions were vortexed for one minute following both the 
addition of polymer and the subsequent addition of the photoinitiator solution. Planar 
hydrogel sheets (1.5 mm thick) were prepared by pipetting the precursor solution 
between two clamped microscope slides (75 x 50 mm) separated by Teflon spacers and 
exposing the mold to longwave UV light (UV-Transilluminator, 6 mW/cm2, 365 nm) for 
a total of 6 min with rotation to the alternate side after 3 min. After removal from the 
mold, the water-based hydrogel sheets were rinsed with DI water and soaked in a Petri 
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dish containing DI water (60 mL) for 2 days with daily water changes to remove catalyst 
impurities. The DCM-based sheets were rinsed with DCM then air dried for 30 min to 
permit evaporation of DCM and subsequently placed in a Petri dish containing DI water 
(60 mL) to remove any remaining DCM. During the first hour of soaking, the water was 
changed every 15 min and thereafter daily for 2 days. All hydrogels were permitted to 
soak in DI water for a total of 72 hr prior to testing.  
2.3.5. Sol Content 
Five discs (13 mm diameter) were punched from a single hydrogel sheet with a 
die. After air-drying for 30 min, each disc was placed in an open scintillation vial and 
dried at room temperature (RT) in a vacuum oven (30 in. Hg, 24 hr). Dried discs were 
then weighed (Wd1), returned to the vial and 10 mL DCM was added to each. The vials 
were capped and placed on a rocker table (250 rpm) for 48 hr to remove sol (i.e. 
uncrosslinked material). The discs were subsequently removed and weighed (Wd2). Sol 
Content is defined as: sol content = [(Wd1 - Wd2)/ Wd1]*100.  
2.3.6. Morphology 
Water-swollen hydrogels discs (13 mm diameter) were flash frozen in liquid 
nitrogen for 1 min and immediately lyophilized for 24 hr (Labconco Centri Vap Gel 
Dryer System). Specimen cross-sections were subjected to Pt/Pd-sputter coating and 
viewed with a field emission scanning electron microscope (FEI Quanta 600 FE-SEM) 
at an accelerated electron energy of 10 keV.  
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2.3.7. Equilibrium Swelling  
Three discs (13 mm diameter) were punched from a single sheet with a die. Each 
disc was placed in a sealed vial containing 20 mL DI water for 48 hr at RT, removed, 
blotted with filter paper to remove surface water, and weighed (Ws). Equilibrium 
swelling ratio is defined as: swelling ratio = (Ws - Wd)/Wd, where Ws is the weight of the 
water-swollen hydrogel and Wd is the weight of the vacuum dried hydrogel (30 in. Hg, 
60 ºC, 24 hr).  
2.3.8. Dynamic Mechanical Analysis (DMA) 
Three discs (13 mm diameter) were prepared as above. Storage modulus (G‟) of 
each disc was measured in the compression mode with a dynamic mechanical analyzer 
(TA Instruments Q800) equipped with parallel-plate compression clamp with a diameter 
of 40 mm (bottom) and 15 mm (top). A water-swollen disc (13 mm diameter) was 
blotted with a Kim Wipe, clamped between the parallel plates and silicone oil placed 
around the exposed hydrogel edge to prevent dehydration. Following equilibration at 25 
°C (5 min), the samples were tested in a multi-frequency-strain mode (1 to 30 Hz).  
2.3.9. Degradation 
Six hydrogel discs (8 mm diameter) were prepared as above. After soaking in DI 
water for 3 hr, an initial swollen weight was recorded. Three discs were each placed into 
a well plate (secured with Parafilm and covered with foil) containing 1 mL 0.05M NaOH 
and maintained at 37 ºC on a rocker table at 50 rpm. The NaOH solution was exchanged 
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every 12 hr.  Swollen weights were recorded at regular intervals (Ws) until the hydrogel 
exhibited a loss in weight with a corresponding loss in mechanical integrity. The time 
required for the disc to completely dissolve was also recorded. The remaining three 
hydrogel discs were vacuum dried (30 in. Hg, 60 ºC, 24 hr) and their weights recorded 
(Wd). S ratio (SR) is defined as: swelling ratio = (Ws - Wd)/Wd. Results reported are 
based on the average of the three individual specimens.  
2.4. Results and Discussion 
2.4.1. Hydrogel Fabrication 
Both the hydrogels formed via SIPS and the conventional hydrogels were 
transparent (Figure 2.2).  However, the cross-section of PEG-DA hydrogels formed by 
SIPS displayed a sponge-like or coarser texture. To verify the efficacy of 
photocrosslinking, sol content values of hydrogels were measured (Supplemental Table 
S1). Sol contents of PEG-DA hydrogels fabricated from DCM precursor solutions (~3-
9%) and aqueous precursor solutions (~1-9%) were similarly low.  
 
 
 
 
Figure 2.2. Macroscopic images of conventional PEG-DA hydrogels fabricated from an aqueous 
precursor solution [left] and PEG-DA hydrogels fabricated via SIPS with a DCM precursor solution (and 
subsequently dried and hydrated) [right]. (PEG-DA: Mn = 6k g/mol; 10 wt% concentration). 
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2.4.2. Morphology 
Conventional PEG-DA hydrogels photopolymerized from aqueous precursor 
solutions  at typical concentrations cannot be imaged via SEM as they collapse during 
the freezing/freeze-drying process [151]. In contrast, SEM images of PEG-DA hydrogels 
prepared via SIPS were obtained and revealed open porous structures (Figure 2.3). 
During SIPS, phase separation of the growing polymer chains and network from the 
solvent leads to polymer rich as well as polymer lean domains (i.e. pores) which upon 
hydration, fill with water. Depending on the extent as well as rate of phase separation 
prior to a final three-dimensional structure determined by significant crosslinking, the 
porosity will vary somewhat. A macroporous morphology was observed when PEG-DA 
hydrogels were prepared at concentrations between 10 and 25 wt%. Notably, for the 
hydrogel series based on 3.4k PEG-DA, higher wt% concentrations produced 
increasingly larger pores. At the same wt% concentration, hydrogels based on 6k PEG-
DA exhibited a different morphology versus the corresponding hydrogel based on 3.4k 
PEG-DA. Thus, SIPS is useful to achieve macroporous morphologies which may be 
tuned by PEG-DA wt% concentration as well as Mn.   
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5 wt% (3k PEG-DA) 5 wt% (6k PEG-DA)
10 wt% (3k PEG-DA) 10 wt% (6k PEG-DA)
15 wt% 6k (PEG-DA)15 wt% (3k PEG-DA)
20 wt% (3k PEG-DA) 20 wt% (6k PEG-DA)
25 wt% (3k PEG-DA) 25 wt% (6k PEG-DA)
Figure 2.3. SEM images of PEG-DA hydrogels fabricated via SIPS. (Scale bars = 100 μm) 
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2.4.3. Equilibrium Swelling  
PEG-DA hydrogels formed via SIPS generally exhibited similar swelling to the 
analogous conventional PEG-DA hydrogel (Figure 2.4). The exceptions are hydrogels 
formed at very low (5 wt%) concentrations which produced substantially lower swelling 
for hydrogels prepared by SIPS.  For a given PEG-DA Mn at a concentration between 
10-25 wt%, rather similar and, in some cases, statistically similar swelling ratios were 
achieved when prepared via SIPS versus from an aqueous precursor solutions. This was 
somewhat unexpected given the macroporous morphology of hydrogels prepared via 
SIPS (Figure 2.3) which is typically associated with enhanced water uptake [94, 154]. 
The lack of swelling increase for PEG-DA hydrogels prepared via SIPS may be 
attributed to reduced water uptake in the polymer-rich regions of the hydrogels. Thus, 
SIPS changes the distribution of water rather than the total water uptake in the resulting 
PEG-DA hydrogels. In addition, certain pairs of PEG-DA hydrogels prepared via SIPS 
at different concentrations also exhibit quite similar swelling ratios (e.g. 6k g/mol at 15 
and 20 wt%). Hydrogel swelling (i.e. hydration) is an important scaffold property given 
its impact on cell behavior in terms of local environment and diffusion of waste and 
nutrients [67]. Thus, the impact of scaffold morphology on cell behavior decoupled from 
total hydration may be studied by utilizing series of PEG-DA scaffolds formed via SIPS 
and conventional PEG-DA hydrogels. 
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2.4.4. Modulus 
During DMA, hydrogel stiffness was measured in terms of the storage modulus 
(G‟) as a function of frequency of the applied strain in compression (Figure 2.5). For a 
given PEG-DA Mn at a specific concentration (5-25 wt%), G‟ was substantially higher 
for hydrogels fabricated via SIPS compared those fabricated from aqueous precursor 
solutions. As previously observed [98, 145] for conventional PEG-DA hydrogels, G‟ 
increased with increasing crosslink density (i.e. reducing PEG-DA Mn) or increasing 
PEG-DA concentration. The same compositional changes to PEG-DA hydrogels 
fabricated via SIPS similarly produced an increase in G‟. For conventional PEG-DA 
hydrogels, increased crosslink density or concentration produces a concomitant decrease 
in swelling such that the impact of G‟ on cell behavior may not be uncoupled from the 
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Figure 2.4. Swelling ratio of PEG-DA hydrogels fabricated with 3.4k g/mol (left) and 6k g/mol (right) 
PEG-DA from a DCM precursor solution (i.e. via SIPS) or from an aqueous precursor solution. Statistical 
significance was determined by student‟s t-test where (*): p < 0.05 and (#): p > 0.05. 
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effect of hydration [146].  From the series of PEG-DA hydrogels formed via SIPS and 
aqueous precursor solutions, a pair or more of hydrogels with similar hydration (Figure 
2.4) but different G‟ (Figure 2.5) are available.  Thus, PEG-DA hydrogels prepared via 
SIPS affords the opportunity to study the influence of modulus on cell behavior 
decoupled from hydration. 
 
 
 
 
 
2.4.5. Degradation 
Increased pore size has been related to faster degradation rates [82, 152] and thus 
represents a strategy to tailor degradation without changing the chemical composition of 
the scaffold material. Because SIPS produces macroporous PEG-DA hydrogels at 10-25 
wt% concentrations (Figure 2.3), it was anticipated that its degradation rate would be 
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faster than the corresponding conventional PEG-DA prepared from aqueous precursor 
solutions. PEG-DA hydrogels were subjected to hydrolytic degradation under 
accelerated (basic) conditions (Figure 2.6). Degradation was measured in terms of the 
time to achieve maximum swelling before loss of mechanical integrity and also in terms 
of time to completely dissolve [160]. For solid aliphatic polyester films, hydrolytic 
degradation rate increases with film thickness due to an autocatalytic effect of more 
slowly diffusing acidic degradation products [169]. In the same way, the degradation 
rate of aliphatic polyester porous materials is increased with larger pore size and hence 
higher pore wall thickness [170]. In the case of PEG-DA hydrogels, hydrolysis of labile 
ester bonds releases poly(acrylic acid) (PAA) kinetic chains [171] which similarly may 
induce autoacceleration if diffusion its limited. Thus, the enhanced rate of degradation of 
PEG-DA hydrogels prepared via SIPS versus conventional hydrogels is attributed to the 
larger pore size and thicker pore wall of the former. As expected, for PEG-DA hydrogels 
prepared via SIPS, lower wt% concentrations led to shorter dissolution times. Also, at 
the same wt% concentration, the degradation rate was higher for hydrogels fabricated 
from 6k g/mol PEG-DA Mn (i.e. hydrogel crosslink density) versus 3.4k PEG-DA. The 
effect of concentration and Mn were similarly observed for conventional PEG-DA 
hydrogels. Given the limited susceptibility to hydrolysis of PEG-DA hydrogels, their 
fabrication by SIPS to produce enhanced degradation rates without alterations to its 
chemical nature is a useful to study cell behavior and ultimately tissue regeneration.  
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2.5. Conclusions 
PEG-DA hydrogels with broader, tunable physical properties which furthermore 
are uncoupled (i.e. not dependent on one another) would be extremely useful to study 
cell-material interaction and ultimately improve tissue regeneration. Towards this goal, 
PEG-DA hydrogels were formed via SIPS with 3.4k and 6k g/mol PEG-DA at various 
wt% concentrations (5-25 wt%). While conventional PEG-DA hydrogels are fabricated 
from an aqueous precursor solution, the reported SIPS protocol utilized a DCM 
precursor solution followed by drying and hydration after photopolymerization. When 
prepared via SIPS, PEG-DA hydrogels displayed a macroporous morphology (10-25 
wt%) but did not exhibit increased total swelling versus the corresponding conventional 
hydrogel. Thus, certain series of hydrogels represent scaffolds in which morphology and 
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Figure 2.6. Swelling ratio as a function of degradation time under basic conditions (0.05 M NaOH) of 
PEG-DA hydrogels fabricated with 3.4k g/mol (left) and PEG-DA 6k g/mol (right) via SIPS at various 
wt% concentrations. [ ] = hours to complete dissolution. ( ) = hours to complete dissolution for 
analogous conventional hydrogels (i.e. prepared from aqueous precursor solutions). 
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hydration are uncoupled. In addition, PEG-DA hydrogels prepared via SIPS exhibited a 
substantial increase in modulus (G‟) versus the corresponding conventional hydrogel. In 
this case, a particular series of hydrogels represent scaffolds in which hydration and 
modulus are uncoupled. Lastly, because of the larger pore size, PEG-DA hydrogels 
fabricated via SIPS exhibited an increased degradation rate under accelerated conditions. 
Thus, PEG-DA hydrogels formed via SIP, particularly when combined with 
conventional PEG-DA hydrogels, form a useful library of scaffolds to study the 
influence of physical properties on cell behavior and ultimately regenerate tissues. 
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CHAPTER III  
PDMSSTAR-PEG HYDROGELS PREPARED VIA SOLVENT-INDUCED PHASE 
SEPARATION (SIPS) AND THEIR POTENTIAL UTILITY AS TISSUE 
ENGINEERING SCAFFOLDS* 
3.1. Overview 
Inorganic-organic hydrogels based on methacrylated star polydimethylsiloxane 
(PDMSstar-MA) and diacrylated poly(ethylene glycol) (PEG-DA) macromers were 
prepared via solvent-induced phase separation (SIPS). The macromers were combined in 
a dichloromethane (DCM) precursor solution and sequentially photopolymerized, dried 
and hydrated (Figure 3.1). The chemical and physical properties of the hydrogels were 
further tailored by varying the number average molecular weight (Mn) of PEG-DA (Mn = 
3.4k and 6k g/mol) as well as the weight % (wt%) ratio of PDMSstar-MA (Mn = 7k 
g/mol) to PEG-DA from 0:100 to 20:80. Compared to analogous hydrogels fabricated 
from aqueous precursor solutions, SIPS produced hydrogels with a macroporous 
morphology, a more even distribution of PDMSstar-MA, increased modulus and 
enhanced degradation rates.  
 
 
 
 
 
*Reprinted with permission from “PDMSstar-PEG hydrogels prepared via solvent-induced phase separation (SIPS) and 
their potential utility as tissue engineering scaffolds” by Brennan M. Bailey, Ruochong Fei, Dany Munoz-Pinto, 
Mariah S. Hahn, and Melissa A. Grunlan, 2012. Acta Biomaterialia, 8, 4324-4333, Copyright [2012] by Acta 
Materialia Inc. Published Elsevier Ltd. 
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The morphology, swelling ratio, mechanical properties, bioactivity, non-specific protein 
adhesion, controlled introduction of cell-adhesion, and cytocompatibility of the 
hydrogels were characterized. As a result of their tunable properties, this library of 
hydrogels is useful to study material-guided cell behavior and ultimate tissue 
regeneration. 
 
 
 
 
 
 
3.2. Introduction 
In tissue engineering, the properties of the three dimensional scaffold guide cell 
behavior and ultimate tissue regeneration [131-135]. Physical properties of scaffolds 
known to impact cell behavior include modulus [74, 86, 87, 140] and morphology (e.g. 
porosity) [77-79, 81, 82, 84, 136, 137, 139, 172]. In addition, scaffold chemical 
properties influence cell behavior including bioactivity,[105, 106, 173] chemical 
functionality,[76] hydrophobicity,[102, 104, 174] and related hydration (i.e. swelling) 
[87, 175]. Therefore, a library of scaffolds having precisely tunable physical and 
PDMSstar-PEG 
DCM precursor solution
 
250 m
1.Photocure
2.Dry
3.Hydrate
Macroscopic image 
of SIPS fabricated 
hydrogel
Macroscopic image of 
SIPS fabricated hydrogel
Figure 3.1. Reported PDMSstar-PEG hydrogel fabrication via SIPS and resulting dissolution and 
distribution of PDMS. 
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chemical properties over a broad range would be a valuable tool to probe material-
guided cell behavior and enable the regeneration of functional tissues.   
Poly(ethylene glycol) diacrylate (PEG-DA) hydrogels are extensively utilized as 
scaffolds for the regeneration of numerous types of tissues [90, 91, 98, 141-144]. Their 
resistance to protein and cell adhesion in the absence of cell adhesive ligands makes 
them particularly useful to study cell-material interactions [88-92]. Thus, changes in cell 
behavior may be related to an associated material property change. However, PEG-DA 
hydrogels display a limited range of physical as well as chemical properties restricting 
their utility for such studies. For instance, the modulus of PEG-DA hydrogels may be 
tuned over a somewhat narrow range by altering the crosslink density (i.e. PEG-DA 
number average molecular weight, Mn) or the weight percent (wt%) concentration of 
PEG-DA in the aqueous precursor solution [98, 145]. However, these alterations 
simultaneously produce changes in swelling thereby restricting the ability to uncouple 
the effect of modulus and swelling on cellular response [176]. While morphological 
changes in general alter cell behavior,[177-179] a macroporous hydrogel morphology 
has shown particular utility in tissue regeneration [79, 97, 151]. PEG-DA (Mn = 3.4k and 
6k g/mol) hydrogels fabricated by the photopolymerization of aqueous precursor 
solutions exhibit pores smaller than ~5-10 μm [128]. Several strategies have been 
explored to produce macroporous PEG-DA hydrogels, including: salt leaching,[153, 
154] gas foaming [157] and cryogelation [155, 156]. However, difficulty leaching 
porogens (salt leaching), high temperatures or low pressures (gas foaming), and 
extremely low temperatures (cryogelation) [158] limits these techniques. 
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In general, the chemical nature of hydrogel scaffolds has been shown to have a 
significant impact on cell behavior [168, 180-183]. Alterations to the chemical nature of 
PEG-DA hydrogels have been largely limited to those that increase the rate of 
degradation. For instance, polyester segments [160, 184] and enzymatically unstable 
peptides [89, 166] have been introduced to enhance the otherwise limited degradation 
rate of PEG-DA hydrogels. The impact of chemical functionality incorporated into PEG-
DA hydrogels on cell behavior has been explored only to a limited extent [76]. Previous 
studies have demonstrated that the incorporation of inorganic silicon-containing 
materials into organic scaffolds enhances their bioactivity [105-107]. In addition, 
scaffold hydrophobicity has also been shown to influence osteogenic differentiation 
[102-104]. Previously, hydrogels were formed by introduction of an inorganic, 
hydrophobic methacrylated star polydimethylsiloxane (PDMSstar-MA) into PEG-DA 
hydrogels [101]. The insolubility of the PDMSstar-MA in the aqueous precursor solutions 
produced hydrogels comprised of discrete PDMSstar-enriched microparticles distributed 
throughout the PEG-DA hydrogel matrix. PDMSstar-MA content altered mechanical 
behavior without significant changes to hydration. Furthermore, previous study showed 
that these PDMS-PEG hydrogel scaffolds demonstrated the ability to guide 
mesenchymal stem cells (MSCs) towards osteogenic differentiation with increased levels 
of  PDMSstar-MA [108].  
Recently, PEG-DA hydrogels were prepared via solvent induced phase 
separation (SIPS) which involved photopolymerization of a dichloromethane (DCM) 
precursor solution followed by sequentially drying and hydration [93]. During SIPS, a 
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solvent system is utilized which promotes phase separation of the growing polymer 
chain and network during cure [94, 95]. Compared to PEG-DA hydrogels fabricated 
from an aqueous precursor solution, hydrogels were macroporous and exhibited 
increased modulus values and enhanced degradation rates. Herein, the introduction of 
variable levels PDMSstar-MA into PEG-DA hydrogels fabricated via SIPS to produce 
bioactive, macroporous PDMSstar-PEG hydrogel scaffolds with enhanced modulus 
values and degradation rates is reported. In contrast to PDMSstar-PEG hydrogels 
fabricated from an aqueous solvent, the improved solubility of PDMSstar-MA in the 
DCM fabrication solvent enables its more homogeneous distribution throughout the 
hydrogel. A series of PDMSstar-PEG hydrogels were prepared via SIPS (i.e. from DCM 
precursor solutions) at 10 wt% total macromer concentration but with variable wt% 
ratios of PDMSstar-MA (7k g/mol) to PEG-DA  (3.4k and 6k g/mol) [0:100, 1:99, 10:90 
and 20:80]. The effect of hydrogel composition on physical and chemical properties, 
including equilibrium swelling (i.e. hydration), morphology, compressive modulus, 
degradation, bioactivity, protein resistance, controlled introduction of cell adhesion and 
cytocompatibility were assessed.  Properties of PDMSstar-PEG hydrogels fabricated via 
SIPS were compared to analogous hydrogels fabricated from an aqueous precursor 
solution. 
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3.3. Materials and Methods 
3.3.1. Materials 
Pt-divinyltetramethyldisiloxane complex (Karstedt‟s catalyst, 2 wt% in xylene), 
tetrakis(dimethylsiloxy)silane (tetra-SiH), and octamethylcyclotetrasiloxane (D4) were 
obtained from Gelest. Allyl methacrylate, acryloyl chloride, triflic acid, 2,2-dimethyl-2-
phenyl-acetophenone (DMAP), 1-vinyl-2-pyrrolidinone (NVP), triethylamine (Et3N), 
MgSO4, K2CO3, hexamethyldisilazane (HMDS), N3013 Nile Red (Nile Blue A 
Oxazone), NaOH, and solvents were obtained from Sigma Aldrich. HPLC grade toluene, 
CH2Cl2, and NMR grade CDCl3 were dried over 4Å molecular sieves. Poly(ethylene 
glycol) (PEG) [PEG-6000; MW = 5000-7000 g/mol and PEG-3400; MW = 3000-3700 
g/mol per manufacturer‟s specifications] were obtained from BioChemika. The Mn of 
PEG-3400 (3371 g/mol) and PEG-6000 (6072 g/mol) were back-calculated from 1H 
NMR end-group analysis of the corresponding diacrylated products. Phosphate buffered 
solution (PBS, pH = 7.4, without calcium and magnesium), HEPES, Dulbecco‟s 
Modified Eagle Medium (DMEM), fetal bovine serum (FBS), PSG solution (10,000 
U/mL penicillin, 10000 mg/L streptomycin, and 29.2 mg/mL  
L-glutamine), and PSA solution (10,000 U/mL penicillin, 10,000 mg/L streptomycin, 
and 25 mg/L amphotericin) were obtained from Mediatech. Peptide RGDS was obtained 
from American Peptide. Acryloyl PEG-succinimidyl valerate (acryloyl-PEG-SVA, 3.4 
kDa) was obtained from Laysan Bio Inc. Mouse smooth muscle precursor cells (10T1/2) 
were obtained from American Type Culture Collection (ATCC). 
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3.3.2. PDMSstar-MA Synthesis 
PDMSstar-MA was prepared as previously reported [185]. First, D4 (29.9 g, 100.8 
mmol), tetra-SiH (1.1 g, 3.3 mmol), triflic acid (60 μL), and HMDS (0.15 g, 0.93 mmol) 
were reacted. In this way, PDMSstar-SiH (24.9 g, 80% yield) was obtained as a colorless 
liquid, Mn/Mw = 7600/18,800 g/mol, PDI = 2.5. 
1H NMR (δ, ppm): 0.064-0.113 (bm, 
1174H, SiCH3), 4.7 (m, 4H, SiH). IR (ν): 2125 cm-1 (Si-H). Next, PDMSstar-SiH (7.0 g, 
0.92 mmol), allyl methacrylate (0.26 g, 2.1 mmol), toluene (30 mL), and Karstedt‟s 
catalyst (100 μL) were reacted to obtain PDMSstar-MA (6.37 g, 88% yield) as a colorless 
liquid, Mn/Mw = 8300/22,000 g/mol, PDI = 2.6. 
1H NMR (δ, ppm): 0.045-0.127 (bm, 
1673H, SiCH3), 0.559 (m, 8H, -SiCH2CH2CH2), 1.67 (m, 8H, -SiCH2CH2CH2), 1.92 (m, 
12H, -C(CH2)CH3), 4.10 (m, 8H, -SiCH2CH2CH2), 5.57 (m, 4H, -C(CH2)CH3), 6.11 (m, 
4H, -C(CH2)CH3). IR (ν): no Si-H peak.   
3.3.3. PEG-DA Synthesis  
PEG-DA (3.4k and 6k g/mol) were prepared as previously reported [101]. PEG-
3400 (23.5 g, 7.0 mmol), Et3N (1.95 mL, 14.0 mmol) and acryloyl chloride (2.27 mL, 
28.0 mmol) were reacted to obtain PEG-DA (15.2 g, 63% yield). 1H NMR (δ, ppm): 
3.62 (s, 297H, -OCH2CH2), 5.81 (dd, 2H, J = 10.5 and 1.2 Hz, -CH=CH2), 6.13 (dd, 2H, 
J = 17.4 and 10.5 Hz, -CH=CH2), 6.40 (dd, 2H, J = 17.3 and 1.5 Hz, -CH=CH2). By 
1H 
NMR end-group analysis, Mn of PEG-DA (3.4k g/mol) was determined to be 3393 g/mol 
(∼3400 g/mol). PEG-6000 (24 g, 4.0 mmol), Et3N (1.12 mL, 8.0 mmol) and acryloyl 
chloride (1.30 mL, 16.0 mmol) were reacted to obtain PEG-DA (31 g, 63% yield). 1H 
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NMR (δ, ppm): 3.61 (s, 547H, -OCH2CH2), 5.81 (dd, 2H, J = 10.4 and 1.5 Hz, -
CH=CH2), 6.13 (dd, 2H, J = 16.8 and 10.5 Hz, -CH=CH2), 6.40 (dd, 2H, J = 17.3 and 
1.5 Hz, -CH=CH2). By 
1H NMR end-group analysis, Mn of PEG-DA (6k g/mol) was 
determined to be 6143 g/mol (∼6000 g/mol). 
3.3.4. NMR 
 
1H NMR spectra were obtained on a Mercury 300 300 MHz spectrometer 
operating in the Fourier transform mode. Five percent (w/v) CDCl3 solutions were used 
to obtain spectra. Residual CHCl3 served as an internal standard.   
3.3.5. Hydrogel Preparation  
PDMSstar-PEG hydrogels formed via SIPS were prepared from DCM-based 
precursor solutions and analogous hydrogels were prepared from aqueous precursor 
solutions at the same concentrations for comparison. First, PEG-DA (3.4k or 6k g/mol) 
was added to either DCM or DI-H2O at 10 wt% total concentration in solvent. PDMSstar-
MA (7k g/mol) was then added at the following wt% ratios of PDMSstar-MA to PEG-
DA: 0:100, 1:99, 10:90 and 20:80. 10 L of photoinitiator solution (30 wt% solution of 
DMAP in NVP) was subsequently added per one mL of the precursor solution. Solutions 
were vortexed for one minute following each addition. Planar hydrogel sheets (1.5 mm 
thick) were prepared by pipetting the precursor solution between two clamped 
microscope slides (75 x 50 mm) separated by Teflon spacers and exposing the mold to 
longwave UV light (UV-Transilluminator, 6 mW/cm2, 365 nm) for a total of 6 min with 
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rotation to the alternate side after 3 min. After removal from the mold, the water-based 
hydrogel sheets were rinsed with DI water and soaked in a Petri dish containing DI water 
(60 mL) for 2 days with daily water changes to remove impurities. The DCM-based 
sheets were rinsed with DCM then air dried for 30 min to permit evaporation of DCM 
and subsequently placed in a Petri dish containing DI water (60 mL) to remove 
impurities and any remaining DCM. During the first hour of soaking, the water was 
changed every 15 min and thereafter daily for 2 days. All hydrogels were permitted to 
soak in DI water for 72 hr prior to testing.  
3.3.6. Sol Content  
 Three discs (13 mm diameter) were punched from a single hydrogel sheet with a 
die. After air-drying (30 min), each disc was placed in an open scintillation vial and 
dried at room temperature (RT) in a vacuum oven (14.7 psi, 24 hr). Dried discs were 
then weighed (Wd1), placed in a new vial and 10 mL DCM was added to each. The vials 
were capped and placed on a rocker table (250 rpm) for 48 hr to remove sol (i.e. 
uncrosslinked material). The discs were subsequently removed, air dried for 30 min, 
placed in an open vial, dried again at RT in a vacuum oven (30 in. Hg, 24 hr) and finally 
weighed (Wd2). Sol Content is defined as: sol content = [(Wd1 - Wd2)/Wd1] x100.  
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3.3.7. Morphology  
3.3.7.1. Scanning Electron Microscopy 
Water-swollen hydrogels discs (13 mm diameter) were flash frozen in liquid 
nitrogen for 1 min and immediately lyophilized for 24 hr (Labconco Centri Vap Gel 
Dryer System). Specimen cross-sections were subjected to Pt-sputter coating and viewed 
with a field emission scanning electron microscope (FEI Quanta 600 FE-SEM) at an 
accelerated electron energy of 10 keV.  
3.3.7.2. Confocal Laser Scanning Microscopy (CLSM)  
For a given hydrogel, a disc (8 mm diameter, 1.5 mm thickness) was punched 
from a hydrogel sheet with a die. A Nile Red solution was prepared as follows: 75 μL of 
a Nile Red solution (20 mg per mL of methanol) was dissolved in 8 mL of DI water and 
combined with 120 mL of PBS. Each hydrogel disc was sequentially soaked for 24 h in 
60 mL of the aforementioned Nile Red solution and then soaked for 3 days in 60 mL of 
PBS (exchanged daily). With each disc placed on a glass microscope slide and DI water 
dropped onto the disc to maintain hydration, images were captured with CLSM using a 
Leica TCS SP5 confocal microscope (Leica Microsystems, Bannockburn, IL; excitation 
filter of 488 nm and emission filter 490-570 nm). Images were obtained from 3 m 
sections in the z-direction. Images were assigned green for contrast. 
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3.3.8. Equilibrium Swelling  
Three discs (13 mm diameter) were punched from a single hydrogel sheet with a 
die. Each disc was placed in a sealed vial containing 20 mL DI water and placed on a 
rocker table (250 rpm) for 48 hr at RT.  Discs were then removed, blotted with filter 
paper to remove surface water, and weighed (Ws). Equilibrium swelling ratio (SR) is 
defined as: SR = (Ws - Wd)/Wd, where Ws is the weight of the water-swollen hydrogel 
and Wd is the weight of the vacuum dried hydrogel (30 in. Hg, 60 ºC, 24 hr).  
3.3.9. Dynamic Mechanical Analysis (DMA)  
Three discs (13 mm diameter) were prepared as above. Storage modulus (G‟) of 
each disc was measured in the compression mode with a dynamic mechanical analyzer 
(TA Instruments Q800) equipped with parallel-plate compression clamp with a diameter 
of 40 mm (bottom) and 15 mm (top). A water-swollen disc (13 mm diameter) was 
blotted with a Kim Wipe, clamped between the parallel plates and silicone oil placed 
around the exposed hydrogel edge to prevent dehydration. Following equilibration at 25 
°C (5 min), the samples were tested in a multi-frequency-strain mode (1 to 25 Hz).  
3.3.10. Degradation  
Six hydrogel discs (8 mm diameter) were prepared as above. After soaking in DI 
water for 3 hr, an initial swollen weight (Ws) was recorded. Three discs were each 
placed into a well of a 24-well plate containing 1 mL 0.05M NaOH, the well plate 
covered with Parafilm and foil and maintained at 37 ºC on a rocker table at 50 rpm. The 
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NaOH solution was exchanged every 12 hr.  Swollen weights (Ws) were recorded at 
regular intervals until the hydrogel exhibited an increase in swelling with a 
corresponding loss in mechanical integrity. The time required for the disc to completely 
dissolve was also recorded. The remaining three hydrogel discs were vacuum dried (30 
in. Hg, 60 ºC, 24 hr) and their weights recorded (Wd). Swelling ratio (SR) is defined as: 
SR = (Ws - Wd)/Wd.  
3.3.11. Bioactivity  
            3.3.11.1. Hydrogel Preparation 
A hydrogel sheet with 0:100 and 10:90 wt% PDMSstar-MA to PEG-DA  
(6 k g/mol) was prepared via SIPS as above. A disc (13 mm diameter) was punched from 
each sheet and each disc placed into a sealed centrifuge tube containing 40 mL of 1.5X 
simulated body fluid (SBF)[186] at 37 C. After two weeks, the hydrogel discs were 
removed and prepared for SEM imaging as above. 
           3.3.11.2. X-ray Diffraction Spectroscopy 
Powder X-ray diffraction data was collected on a Bruker D8 diffractometer  
fitted with LynxEYE detector (CuKa; 40kV, 40 mA; Bragg Brentano geometry;  
scan range: 5 - 70 degrees; step size: 0.05 degrees; step time: 1 s). 
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3.3.12. Nonspecific Protein Adhesion  
The adhesion of Alexa Fluor 555 dye conjugate of bovine serum albumin (AF-
555 BSA; MW = 66 kDa; Molecular Probes, Inc.) onto hydrogels was studied by 
fluorescence microscopy. For a given hydrogel, three hydrogel discs (14 mm diameter, 
1.5 mm thickness) were punched from a single hydrogel sheet and placed in PBS (15 
min) to ensure hydration. Immediately prior to transferring to a 24-well plate, discs were 
gently blotted with filter paper to remove PBS on the surface. Of the three discs, two 
discs were each placed in wells containing 1.5 mL of BSA (0.1 mg/mL of PBS) and the 
third disc was placed in a well containing 1.5 mL of PBS. Hydrogel discs were 
maintained in the dark at RT for 3 h. Next, from both the top and bottom surfaces of the 
discs, the BSA solution was carefully removed via aspiration and both sides of the disc 
were rinsed with fresh PBS 3 times for 1 h each time to permit the diffusion of 
unadsorbed protein out of the hydrogels before imaging. No measurable internal 
fluorescence signal was detected following rinsing. Each of these discs was returned to a 
well containing 1.5 mL of fresh PBS for imaging. 
A Zeiss Axiovert 200 optical microscope equipped with an A-Plan 5X objective 
(Axiocam HRC Rev. 2), and filter cube (excitation filter of 546 ( 12 nm [band-pass] and 
emission filter 575-640 nm [bandpass]) was used to obtain fluorescent images on three 
randomly selected regions of each hydrogel surface. The fluorescent light source was 
permitted to warm up for 30 min prior to image capture. Linear operation of the camera 
was ensured and constant exposure time used during the image collection to permit 
quantitative analyses of the observed fluorescent signals. The fluorescence microscopy 
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images were analyzed using ImageJ, which yielded the mean and standard deviation of 
the fluorescence intensity within a given image. For a given hydrogel composition, the 
average fluorescence intensity of the two discs exposed to AF-555 BSA was subtracted 
from that of the disc maintained only in PBS to ensure correction for of any fluorescence 
signal from the material itself. The background corrected fluorescence intensities for 
each hydrogel were then used to quantify AF-555 BSA levels adsorbed by comparison 
against a calibration curve constructed from the measured fluorescence intensities of AF-
555 BSA standard solutions. Standard solutions were prepared at 0, 0.005, 0.01, 0.02, 
and 0.04 mg/mL AF-555 BSA in PBS and each placed into an individual well. 
3.3.13. Controlled Introduction of Cell Adhesion and Spreading  
Hydrogel sheets were prepared with and without acrylate-derivatized cell-
adhesive peptide RGDS in the DCM precursor solutions. RGDS-modified hydrogel 
sheets (50 x 40 x 1 mm) were fabricated at different wt% ratios of PDMSstar-MA to 
PEG-DA (3.4k g/mol) [0:100, 1:99, 10:90 and 20:80] via SIPS as above but with 1 
μmol/mL (post-swelling) of acrylate-derivatized RGDS in the DCM precursor solutions. 
Acryloyl-PEG-RGDS was prepared by reacting acryloyl-PEG-SVA (3.4 kDa) with 
RGDS.[187] A PEG-DA hydrogel fabricated in water (“PEG Control”) was similarly 
formed with acrylate-derivatized RGDS from an aqueous precursor solution. The DCM-
based sheets were first air dried for 24 hr. Both the water-based and dried DCM-based 
sheets were  sterilized with two changes of ethanol/water (70/30; 24 h) and transferred 
into sterile Petri dishes where they were washed twice with sterile DI water (24 hr) and 
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finally rinsed twice with Dulbecco‟s PBS (pH = 7.2) supplemented with 1% PSA (24 
hr). Four (8 mm diameter) discs were punched from each sample and transferred into a 
48 well plate. 10T ½ cells were seeded onto the hydrogel surfaces at 10,000 cells/cm2. 
After being maintained for 24 hr at 37 C with 5% CO2 in DMEM (without phenol red) 
supplemented with 10% heat-inactivated FBS and 1% PSG, cell adhesion and spreading 
was examined at 24 h using a bright field microscopy (Zeiss Axiovert).  
3.3.14. Cytocompatibility  
Hydrogel sheets prepared for cell adhesion and spreading studies were likewise 
prepared for cytocompatiblity tests.  Hydrogel cytocompatiblity was assessed by 
measuring lactate dehydrogenase (LDH) levels released by 10T ½ cells 24 hr following 
cell seeding. Following the aforementioned sterilization protocol, four 8 mm hydrogel 
discs per sample type were transferred to separate wells of a 48 well plate. Harvested 
10T ½ cells were seeded onto the hydrogel surfaces at 6000 cells/cm2. After being 
maintained for 24 hr at 37 C as above, the media surrounding each specimen was 
collected for LDH measurements following manufacturer (Roche) protocol. 
3.4. Results and Discussion 
3.4.1. Hydrogel Fabrication  
Figure 3.2 shows the appearance of precursor solutions and the corresponding 
hydrogel. As was previously observed,[93] pure PEG-DA hydrogels fabricated via SIPS 
were similarly transparent compared to the corresponding PEG-DA hydrogel (i.e. 
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fabricated from an aqueous precursor solution). Aqueous precursor solutions became 
hazy upon addition of hydrophobic PDMSstar-MA due to its water-insolubility [101] 
(Figure 3.2). Due to the improved solubility of PDMSstar-MA in DCM, precursor 
solutions were less hazy and the corresponding hydrogels were not as opaque. To 
validate photocrosslinking efficacy, hydrogel sol contents were measured. Sol content 
values of PDMSstar-PEG hydrogels fabricated from DCM precursor solutions (~2-11%) 
and aqueous precursor solutions (~0.5-8%) were similarly low (Table 3.1).  
 
 
 
 
(20:80) 
DCM 
(0:100) 
H2O 
(20:80) 
H2O 
(0:100) 
DCM 
Figure 3.2. Precursor solutions [top] and corresponding hydrogels [bottom] formed from an aqueous 
precursor solution (left) and via SIPS (right) (i.e. with a DCM precursor solution followed by 
subsequent drying and hydration) with 6k g/mol PEG-DA. 
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3.4.2. Morphology and Distribution of PDMS  
Recently, macroporous PEG-DA hydrogels were prepared via SIPS by 
employing a DCM precursor solution [93]. During SIPS, macropores are produced by 
the separation of the growing polymer chains and network from the solvent into polymer 
rich and polymer lean domains (i.e. pores) that subsequently fill with water during 
hydration. Because pure PEG-DA hydrogels formed via SIPS did not significantly 
collapse during prior freeze-drying, their morphology could be examined by SEM [93]. 
However, SEM images of PDMSstar-PEG hydrogels revealed that they had significantly 
collapsed (Figure 3.3).  
Thus, the porosity as well as PDMSstar-MA distribution of hydrated hydrogels 
was characterized with CLSM (Figure 3.4). Regions of the hydrogels containing the 
Table 3.1. Sol Content of SIPS and analogous conventional hydrogels. 
 
Hydrogel  
formed  by 
SIPS 
 
 
 
 
% sol content 
 
Hydrogel formed 
in water 
 
% sol content 
PEG-DA: Mn = 3.4k  g/mol  PEG-DA: Mn = 3.4k g/mol  
PDMSstar-PEG wt%  PDMSstar-PEG wt%  
0:100 3.9 ± 1.6 0:100 0.5 ± 0.7 
1:99 2.0 ± 2.8 1:99 5.7 ± 1.2 
10:90 4.0 ± 0.2 10:90 7.2 ± 1.4 
20:80 6.7 ± 5.0 20:80 8.4 ± 0.7 
PEG-DA: Mn = 6k g/mol  PEG-DA: Mn = 6k g/mol  
PDMSstar-PEG wt%  PDMSstar-PEG wt%  
0:100 3.2 ± 0.8 0:100 5.0 ± 0.8 
1:99 2.8 ± 0.4 1:99 5.6 ± 0.4 
10:90 5.0 ± 1.2 10:90 5.5 ± 1.9 
20:80 10.8 ± 0.3 20:80 4.3 ± 1.7 
a Prepared from an aqueous precursor solution 
b Data taken from ref 60. 
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hydrophobic PDMSstar-MA were stained by the hydrophobic dye whereas water-filled 
pores were unstained. With increased levels of PDMSstar-MA, hydrogel pore size 
increased and became macroporous at wt% ratios ≥ 10 wt%. Furthermore, the PDMSstar-
MA is more uniformly distributed versus analogous PDMSstar-PEG hydrogels fabricated 
from an aqueous precursor solution in which discrete  PDMS-enriched microparticles 
were observed [101]. Thus, SIPS is useful to achieve macroporous morphologies as well 
as a more uniform distribution of PDMS.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(3k) PDMS:PEG (0:100) (6k) PDMS:PEG (0:100) 
(3k) PDMS:PEG (1:99) (6k) PDMS:PEG (1:99) 
(3k) PDMS:PEG (10:90) (6k) PDMS:PEG (10:90) 
(3k) PDMS:PEG (20:80) (6k) PDMS:PEG (20:80) 
Figure 3.3. SEM images of PDMSstar-PEG hydrogels fabricated via SIPS. (scale bars = 50 μm) 
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3.4.3. Equilibrium Swelling 
Swelling of PDMSstar-PEG hydrogels formed via SIPS was lower than that of the 
corresponding PDMSstar-PEG hydrogels produced from aqueous precursor solutions 
(Table 3.2, Figure 3.5). For “water fabricated” PDMSstar-PEG hydrogels, PDMSstar-MA 
content did not substantially alter hydration, likely due to the discrete nature of the 
(3.4k) PDMS:PEG (1:99) (6k) PDMS:PEG (1:99) 
(6k) PDMS:PEG (10:90) (3.4k) PDMS:PEG (10:90) 
(3.4k) PDMS:PEG (20:80) (6k) PDMS:PEG (20:80) 
Figure 3.4. CLSM images of hydrated PDMSstar-PEG hydrogels prepared with different wt% ratios of 
PDMSstar-MA:PEG-DA from a DCM precursor solution (i.e. via SIPS). PDMS-enriched regions stained 
with hydrophobic dye (Nile Red). (scale bars = 250 μm) 
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PDMS-enriched microparticles. Hydrophobic PDMSstar-MA is more soluble in DCM 
versus water and so becomes more evenly distributed throughout the hydrogels prepared  
via SIPS (Figure 3.4). As a result, increased PDMSstar-MA content produced a 
systematic decrease in swelling. While the macroporous nature of PDMSstar-PEG 
hydrogels formed via SIPS is expected to increase swelling [94, 154]. PEG-DA 
hydrogels prepared via SIPS likewise did not exhibit enhanced swelling versus PEG-DA 
hydrogels fabricated from aqueous precursor solutions [93] which may be due to 
reduced swelling of polymer-rich region. Thus, the distribution of water rather than total 
water uptake is changed by using SIPS to form PDMSstar-PEG hydrogels. 
 
Table 3.2. Hydrogel Swelling Ratio and Adsorption of BSA Protein. 
 
Hydrogel  
formed   
by SIPS 
 
 
 
Swelling  
Ratio 
 
mg BSA 
adsorbed per 
cm
2
 (x 10
-4
)
b 
 
 Hydrogel formed 
in water
a
 
Swelling  
Ratio 
mg BSA 
adsorbed per 
cm
2
 (x 10
-4
)
b
 
Mn = 3.4k  g/mol (PEG-DA)   Mn = 3.4k g/mol (PEG-DA)  
   PDMSstar-PEG wt%   PDMSstar-PEG wt%   
0:100 7.2 ± 0.01 2 ± 0.4  0:100 8.6 ± 0.02  5 ± 1 
1:99 7.0 ± 0.04 25 ± 2  1:99 8.5 ± 0.03 14 ± 6 
10:90 5.7 ± 0.04 10 ± 3  10:90 7.8 ± 0.02  6 ± 3 
20:80 4.9 ± 0.09 19 ± 6  20:80 7.6 ± 0.09 19 ± 2 
PEG Mn = 6k g/mol (PEG-DA) 
  
PEG Mn = 6k g/mol (PEG-DA) 
   PDMSstar-PEG wt%   PDMSstar-PEG wt% 
0:100 9.8 ± 0.09 10 ± 7  0:100 9.3 ± 0.2 12 ± 5 
1:99 9.1 ± 0.10 16 ± 2  1:99 9.7 ± 0.1 15 ± 2 
10:90 7.6 ± 0.06 11 ± 2  10:90 9.2 ± 0.1 13 ± 3 
   20:80 6.5 ± 0.13 19 ± 6  20:80 8.8 ± 0.1 10 ± 1 
a Prepared from an aqueous precursor solution 
b Data taken from ref 60. 
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3.4.4. Modulus 
Hydrogel stiffness was quantified in term of the compressive storage modulus 
(G‟) obtained by DMA (Figure 3.6). As previously reported for PED-DA hydrogels,[98, 
188] G‟ of PDMSstarPEG hydrogels prepared via SIPS increased with higher crosslink 
density (i.e. lower PEG-DA Mn). G‟ was substantially higher for hydrogels fabricated 
via SIPS compared to the corresponding hydrogels fabricated from aqueous precursor 
solutions. There are two contributing factors to this observation. First, for a given 
composition, PDMSstar-PEG hydrogels prepared via SIPS exhibited reduced swelling 
(Figure 3.5) which is typically associated with enhanced rigidity [175]. Second is the 
effect of the macroporous morphology of the hydrogels prepared via SIPS (Figure 3.4). 
Indeed, despite minor changes in swelling, pure PEG-DA hydrogels prepared via SIPS 
were macroporous and exhibited a pronounced increase in G‟ versus when fabricated in 
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Figure 3.5. Swelling ratio of PDMSstar-PEG hydrogels fabricated with 3.4k g/mol (left) and 6k g/mol 
(right) PEG-DA from a DCM precursor solution (i.e. via SIPS) or from an aqueous precursor solution. 
Statistical significance was determined by student‟s t-test where (*): p < 0.05 and (#): p > 0.05. 
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water [93]. For hydrogels formed via SIPS, the associated thicker pore walls may be the 
source of the increase in G‟. 
 
 
 
3.4.5. Degradation 
Hydrolytic degradation of PDMSstar-PEG hydrogels was measured under 
accelerated (basic) conditions (Figure 3.7). Degradation was quantified in terms of the 
time to reach maximum swelling before loss of mechanical integrity as well as the time 
for complete dissolution [160]. For aliphatic polyesters, the rate of hydrolytic 
degradation increases with larger pore size and hence greater pore wall thickness [82] as 
well as film thickness [169] due to an autocatalytic effect of more slowly diffusing 
acidic degradation products. Under basic conditions, macroporous PEG-DA hydrogels 
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Figure 3.6. Storage modulus (G‟) of PDMSstar-PEG hydrogels fabricated with 3.4k g/mol (left) 
and 6k g/mol (right) from a DCM precursor solution (i.e. via SIPS) [solid lines] or from an 
aqueous precursor solution [dashed lines]. 
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formed via SIPS likewise degraded faster than the corresponding hydrogel fabricated 
from aqueous precursor solutions [93].  For PEG-DA-based hydrogels, hydrolysis of 
ester bonds releases poly(acrylic acid) (PAA) kinetic chains [171] capable of inducing 
autoacceleration if diffusion is limited. However, under basic conditions, the increased 
degradation rate may be largely attributed to the limited diffusion of hydroxide ions 
through thicker pore walls which proceed to catalyze bond cleavage. Likewise, the 
observed increased degradation rate of PDMSstar-PEG hydrogels fabricated via SIPS 
versus the corresponding hydrogel fabricated in water is attributed to the former‟s 
increased pore size and thicker pore walls. As expected, degradation rate increased for 
hydrogels prepared with 6k g/mol PEG-DA versus from 3.4k g/mol PEG-DA due to the 
former‟s lower crosslink density. The effect of Mn was similarly observed for PDMSstar-
PEG hydrogels fabricated from aqueous precursor solutions (Figure 3.8). Incorporation 
of PDMSstar-MA into hydrogels formed via SIPS led to an increased degradation time 
but did not necessarily coincide with PDMSstar-MA content. For these hydrogels, as 
PDMSstar-MA content increases, the degradation rate is influenced by both the increased 
hydrophobicity that reduces degradation [189] and the increased pore size that enhances 
degradation. Given the limited susceptibility to hydrolysis of PEG-DA-based hydrogels, 
their fabrication by SIPS to produce enhanced degradation rates as well as the ability to 
further increase degradation rates through the incorporation of PDMSstar-MA provide 
useful mechanisms to enhance the utility of PEG-DA hydrogels for tissue engineering. 
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Figure 3.7. Swelling ratio under basic conditions (0.05 M NaOH) of PDMSstar-MA:PEG-DA 
hydrogels fabricated via SIPS with 3.4k g/mol (left) and 6k g/mol (right) PEG-DA. [ ] = hours to 
complete dissolution and ( ) = hours to complete dissolution of analogous hydrogel (i.e. fabricated 
from aqueous precursor solutions). 
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Figure 3.8. Swelling ratio under basic conditions (0.05 M NaOH) of PDMSstar-MA:PEG-DA 
hydrogels fabricated via SIPS with 3.4k g/mol (left) and 6k g/mol (right) PEG-DA. ( ) = hours to 
complete dissolution. 
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3.4.6. Bioactivity - Hydroxyapatite Formation  
Bioactive materials chemically bond to bone via formation of a biological active 
hydroxyapatite (HAp) layer [190]. Calcium apatites such as HAp have also been shown 
to promote differentiation of mesenchymal stem cells (MSCs) to osteoblasts (i.e. are 
osteoinductive) [191]. Since inorganic, hydrophobic materials are associated with 
bioactivity,[105, 106, 173] it was anticipated that PDMSstar-PEG hydrogels prepared via 
SIPS would be bioactive. The degree of formation of HAp upon immersion into SBF is a 
qualitative indication of the level of scaffold bioactivity and has been correlated to the 
ability to bond to bone in vivo [192]. Thus, the extent of formation of HAp following 
SBF exposure was compared for a PDMSstar-PEG (3.4k g/mol) hydrogel (10:90 wt% 
ratio) versus the pure PEG-DA (3.4k g/mol) control (i.e. no PDMS) and PDMSstar-PEG 
(6k g/mol) hydrogel (20:80 wt% ratio) versus the pure PEG-DA (6k g/mol) control (i.e. 
no PDMS) (Figure 3.9). SEM images revealed a significant level of HAp on the 
PDMSstar-PEG hydrogel but its absence on the PEG-DA hydrogel. X-ray diffraction was 
performed on these hydrogel compositions to verify HAp formation and characteristic 
HAp peaks of 31.7, 45.5, and 56.5 were noted. These peaks indicate reflections from 
112, 222, 004 crystal planes respectively and correspond to Bragg reflections of HAp 
(Figure 3.10) [193]. In previous studies, PDMSstar-PEG hydrogels prepared from 
aqueous precursor solutions demonstrated increased stimulation of osteogenic 
differentiation of encapsulated MSCs [108].  On the basis of these studies, PDMSstar-
PEG hydrogels prepared via SIPS are bioactive and may increase the osteogenic 
potential of associated MSCs. 
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Figure 3.10. X-ray Diffraction of PDMS:PEG (3.4k and 6k g/mol) hydrogels soaked in SBF - 
revealing the formation of HAp within hydrogels when PDMS is incorporated (dotted line) and 
absence of HAp when no PDMS is incorporated (solid line). 
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Figure 3.9. SEM images (following exposure to SBF for 2 weeks) of hydrogels fabricated with either 
3.4k (top) or 6k g/mol (bottom) PEG-DA from a DCM precursor solution (i.e. via SIPS) with (right 
column) and without PDMS (left column) (scale bars = 50 μm). 
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3.4.7. Nonspecific Protein Adhesion 
Because cell behavior is altered by adsorbed proteins (e.g. from serum),[89, 194] 
scaffolds useful to study materials-guided cell behavior must be significantly protein 
resistant. The adsorption of BSA onto PDMSstar-PEG hydrogels prepared via SIPS was 
compared to that of the corresponding PEG-DA hydrogels (Table 3.2). BSA adsorption 
on PEG-DA hydrogels has been shown to increase with reduced hydration [195]. As 
noted above, swelling was reduced with increased PDMSstar-MA content for PDMSstar-
PEG hydrogels prepared via SIPS. When based on 6k g/mol PEG-DA, PDMSstar-PEG 
hydrogels formed via SIPS exhibited somewhat similar BSA adsorption versus the pure 
PEG-DA control. BSA adsorption was somewhat higher for hydrogels based on 3.4k 
g/mol PEG-DA versus the PEG-DA control. This may be due to the lower hydration of 
hydrogels based on 3.4k g/mol versus 6k g/mol PEG-DA. However, for all PDMSstar-
MA:PEG-DA hydrogels, protein adsorption levels were within the range reported for 
PEG-DA hydrogels [195]. Furthermore, BSA adsorption was similar for PDMSstar-PEG 
hydrogels prepared by SIPS versus that of analogous hydrogels prepared in water, 
despite the former‟s reduced swelling. The increased pore size of PDMSstar-PEG 
hydrogels prepared by SIPS may enhance protein diffusion thereby reducing its 
adsorption.  
3.4.8. Controlled Introduction of Cell Adhesion and Spreading  
PEG-DA hydrogels‟ resistance to adsorption of bioactive serum proteins renders 
them “biological blank slates” as cells are subsequently unable to adhere and spread 
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[92]. Defined levels of cell adhesion may be introduced by covalent incorporation of 
acrylate-functionalized cell adhesive peptide RGDS into PEG hydrogels [88, 196, 197]. 
While minor changes in protein adsorption were observed, maintenance of the biological 
blank slate nature for PDMSstar-PEG hydrogels was assessed by evaluating cell adhesion 
onto hydrogels prepared with and without acrylate-RGDS (Figure 3.11). PDMSstarPEG 
hydrogels based on 3.4k g/mol PEG-DA were prepared via SIPS both with and without 1 
mol/mL of acrylate-derivatized RGDS. A PEG-DA hydrogel fabricated in water 
similarly prepared with and without RGDS served as a control (“PEG Control”). 
Incorporation of low levels of RGDS  has been observed to cause only a minute change 
in hydrogel swelling [198]. As with the PEG control, cells did not adhere and spread in 
the absence of RGDS. However, modification of all hydrogels with RGDS did cause cell 
adhesion and spreading. Thus, as for “water fabricated” PEG-DA hydrogels, PDMSstar-
PEG hydrogels prepared via SIPS permit the controlled introduction of cell adhesion and 
spreading which is critical for their utility to study cell-material interactions.   
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3.4.9. Cytocompatibility  
 Low cytotoxicity of PDMSstar-PEG hydrogels prepared via SIPS is essential for 
their utility as tissue engineering scaffolds. Cytocompatiblity was assessed by measuring 
LDH levels released by 10T½ cells 24 hr post-seeding onto RGDS-modified hydrogels 
based on 3.4k g/mol PEG-DA as a representative series (Figure 3.12). LDH is a soluble 
cytosolic enzyme that is released into the culture medium following membrane damage 
due to apoptosis or necrosis [199]. Thus, differences in the normalized levels of 
exogenous LDH across cell-laden hydrogels are indicative of the amount of cell death 
induced by the hydrogel composition. At all levels of PDMSstar-MA, the relative LDH 
activity associated with PDMSstar-PEG hydrogels prepared via SIPS were similar to pure 
PEG-DA hydrogels prepared via SIPS as well as PEG-DA hydrogels fabricated from 
aqueous precursor solutions.  Thus, at these levels of PDMSstar-MA, PDMSstar-PEG 
hydrogels maintain the low cytotoxicity of PEG-DA hydrogels. 
 
Figure 3.11. Cell spreading for PDMS-PEG hydrogels prepared without [top] and with [bottom] RGDS 
(cell-adhesive peptide). PEG Control = PEG-DA hydrogel (3.4k g/mol) prepared from an aqueous 
precursor solution. [Scale bars = 50 µm].  
 60 
 
 
 
 
 
 
 
 
 
 
 
 
3.5. Conclusions 
Hydrogels which maintain the useful properties of PEG-DA hydrogels but extend 
their physical and chemical properties would be useful for controlled cell-material 
interaction studies. In this study, PDMSstar-PEG hydrogels were fabricated via SIPS to 
produce macroporous morphologies and a more even distribution of bioactive PDMS 
versus when fabricated from an aqueous precursor solution. Hydrogel properties were 
tuned by adjusting the wt% ratio of PDMSstar-MA:PEG-DA (0:100, 1:99, 10:90 an 
20:80) as well as PEG-DA Mn (3.4k or 6k g/mol). A pronounced increase in hydrogel 
stiffness (G‟) was observed for PDMSstar-PEG hydrogels fabricated via SIPS versus the 
corresponding hydrogel fabricated from an aqueous precursor solution and was shown to 
increase with PDMSstar-MA content. In addition, the degradation rate was enhanced for 
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Figure 3.12. Relative LDH activity (24 hr) of PDMSstar-PEG hydrogels fabricated with 3.4k g/mol PEG-DA 
from a DCM precursor solution (i.e. via SIPS) with varying wt% ratio PDMSstar-MA:PEG-DA. PEG Control 
= PEG-DA hydrogel (3.4k g/mol) prepared from an aqueous precursor solution. All formulations were 
statistically similar versus each other (ANOVA, p < 0.05). 
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hydrogels formed via SIPS. While PEG-DA hydrogels did not demonstrate bioactivity 
(i.e. formation of HAp upon submersion into SBF), PDMSstar-PEG hydrogels fabricated 
via SIPS were bioactive. This is attributed to the hydrophobic, inorganic nature of the 
PDMS. SIPS-produced PDMSstar-PEG hydrogels did substantially adsorb higher levels 
of BSA versus a PEG-DA hydrogel fabricated in water. As a result, cell adhesion and 
spreading onto PDMSstar-PEG hydrogels was observed only on hydrogels modified with 
the cell adhesive peptide RGDS. Thus, these PDMSstar-PEG hydrogels maintain the 
biological blank slate nature of “water fabricated” PEG-DA hydrogels.  Thus, these new 
PDMSstar-PEG hydrogels formed by SIPS are useful to use, along with pure PEG-DA 
and PDMSstar-PEG hydrogels formed from aqueous precursor solutions, to study 
materials-guided cell behavior and tissue regeneration.   
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CHAPTER IV  
CONTINUOUS GRADIENT SCAFFOLDS FOR RAPID SCREENING OF CELL-
MATERIAL INTERACTIONS AND INTERFACIAL TISSUE REGENERATION* 
4.1. Overview 
In tissue engineering, the physical and chemical properties of the scaffold 
mediates cell behavior including regeneration. Thus, a strategy that permits rapid 
screening of cell-scaffold interactions is critical. Herein, eight “hybrid” hydrogel 
scaffolds have been prepared in the form of continuous gradients such that a single 
scaffold contains spatially varied properties (Figure 4.1). These scaffolds are based on 
combining an inorganic macromer [methacrylated star polydimethylsiloxane, PDMSstar-
MA] and organic macromer [poly(ethylene glycol)diacrylate, PEG-DA] as well both 
aqueous and organic fabrication solvents.  
 
 
 
 
 
 
 
 
 
*Reprinted with permission from “Continuous gradient scaffolds for rapid screening of cell-material interactions and 
interfacial tissue regeneration” by Brennan M. Bailey, Lindsay N. Nail and Melissa A. Grunlan, 2013. Acta 
Biomaterialia, in press online, Copyright [2013] by Acta Materialia Inc. Published Elsevier Ltd. 
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Having previously demonstrated its bioactivity and osteoinductivity, PDMSstar-MA is a 
particularly powerful component to incorporate into instructive gradient scaffolds based 
on PEG-DA. The following parameters were varied to produce the different gradients or 
gradual transitions in: (1) the wt% ratio of PDMSstar-MA to PEG-DA macromers, (2) the 
total wt% macromer concentration, (3) the number average molecular weight (Mn) of 
PEG-DA and (4) the Mn of PDMSstar-MA. Upon dividing each scaffold into four “zones” 
perpendicular to the gradient, it was found that spatial variation in morphology, 
bioactivity, swelling and modulus was demonstrated. Among these gradient scaffolds are 
those in which swelling and modulus are conveniently decoupled. In addition to rapid 
screening of cell-material interactions, these scaffolds are well-suited for regeneration of 
interfacial tissues (e.g. osteochondral tissues) that transition from one tissue type to 
another. 
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Figure 4.1. Gradient fabrication and compositions. The fabrication method (top) and eight resulting 
scaffolds possessing continuous gradients (bottom) based on a gradual transition in: (a) the wt% ratio of 
PDMSstar-MA to PEG-DA macromers, (b) the total wt% macromer concentration, (c) the Mn of PEG-DA 
and (d) the Mn of PDMSstar-MA. A constant wt% ratio of PDMSstar-MA to PEG-DA was maintained for b-
d. Each scaffold was fabricated in both DI-H2O and DCM to vary PDMSstar-MA distribution, scaffold 
porosity and modulus. Note, when fabricated from a DCM precursor solution, the resulting network was 
dried (i.e. DCM removal) and hydrated with water before testing. 
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4.2. Introduction 
As with the extracellular matrix (ECM) in natural tissues, properties of the tissue 
engineering scaffold direct cell behavior and thus tissue regeneration [131, 132].  These 
include both physical properties (e.g. morphology or porosity[77, 81, 136] and 
modulus[86, 87, 140]) and chemical properties (e.g. chemical functionality,[75, 76, 105] 
hydrophobicity,[102, 174] hydration[87, 128, 175] and bioactivity[105, 106]). 
Importantly, recent studies suggest that these scaffold properties (e.g. modulus) may be 
as potent as growth factors in terms of directing stem cell fate [85, 86, 200]. As a result, 
scaffolds with properties precisely tuned for optimal cell regeneration have the potential 
to form tissues with properties closely resembling those of native tissues [1, 201]. Yet, 
scaffold-guided cell behavior is difficult to elucidate given the labor-intensive practice of 
evaluating a large number of individual scaffolds whose compositions and hence 
properties are iteratively varied. Thus, the development of a strategy that permits 
systematic and rapid screening of cell–scaffold interactions, particularly for a scaffold 
system with a broad range of properties, is critical. Combinatorial strategies have mainly 
been limited to two-dimensional (2D) culture in which arrays of isolated, individual 
scaffolds are rapidly produced and cells cultured on the surfaces [202-204]. However, 
three-dimensional (3D) culture is preferred as it better resembles the native tissue 
environment [205-207]. In this study, hydrogel scaffolds suitable for 3D culture have 
been prepared in the form of continuous gradients such that a single scaffold contains 
spatially varied properties. Thus, cell-material interaction studies may be conducted and 
compared among different “zones” defined along the gradient. These continuous 
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gradient hydrogel scaffolds not only allow for rapid screening of cell-material 
interactions, but scaffolds prepared in this way would ultimately be useful for 
regeneration of interfacial tissues which require scaffolds possessing spatially organized 
material compositions [114, 115].  
Three-dimensional continuous gradients have been reported [110-113]. Recently, 
Chatterjee and co-workers used a gradient maker to produce continuous gradient 
hydrogel scaffolds based an organic macromer [poly(ethylene glycol)-diacrylate, PEG-
DA] and an aqueous fabrication solvent [114]. In this study, this method has been 
applied to prepare “hybrid” continuous gradient hydrogel scaffolds based on combining 
an inorganic and organic macromer and using both aqueous and organic fabrication 
solvents. In previous work, introduction of inorganic, hydrophobic methacrylated star 
polydimethylsiloxane (PDMSstar-MA) to PEG-DA hydrogels prepared with aqueous 
solvent broadened both chemical and physical properties [101]. Later, it was 
demonstrated that both PEG-DA and PDMSstar-PEG hydrogels could be prepared via 
solvent-induced phase separation (SIPS) by employing dichloromethane as an organic 
fabrication solvent followed by sequential solvent removal and hydration after curing 
[100, 208]. SIPS produced hydrogels with low sol contents and low cytotoxicity as well 
as increased pore size, enhanced modulus and a more uniform distribution of PDMSstar-
MA versus analogous hydrogels fabricated from aqueous precursor solutions. In 
addition, PDMSstar-PEG hydrogels fabricated from aqueous precursor solutions were 
bioactive, forming hydroxyapatite when exposed to simulated body fluid (SBF)[100] and 
furthermore resulted in an increase in osteogenic differentiation of encapsulated 
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mesenchymal stem cells (MSCs) in proportion to PDMSstar-MA content [108]. Based on 
these properties, this hybrid PDMSstar-PEG hydrogel scaffold system is particularly of 
interest for bone and osteochondral tissue engineering. More broadly speaking, this 
approach represents a general method by which a dual-component polymer scaffold 
system may be prepared as continuous gradients for rapid screening. 
Herein, eight different continuous gradient hybrid scaffolds were prepared with 
spatially controlled chemical and physical properties (Figure 4.1). The following 
parameters were varied to produce the different “gradients” or gradual transitions in:  
(1) the wt% ratio of PDMSstar-MA to PEG-DA macromers, (2) the total wt% macromer 
concentration, (3) the number average molecular weight (Mn) of PEG-DA and (4) the Mn 
of PDMSstar-MA. Each gradient scaffold was made with both aqueous (distilled water, 
DI-H2O) and organic (dichloromethane, DCM) fabrication solvents. These scaffolds 
were formed using a standard laboratory gradient maker (Figure 4.1). The stock and 
mixing chambers contained the designated precursor solutions (i.e. macromers, 
fabrication solvent and photocatalyst). A peristaltic pump and tubing were used to move 
the gradient maker output to a top-filling vertical mold (8 cm x 6 cm x 3 mm) consisting 
of two clamped rectangular glass slides separated by a U-shaped Teflon spacer. After 
filling, the mold was immediately exposed to UV light for 6 min (alternating sides after 
3 min) to effect crosslinking. In the case of scaffolds prepared from a DCM precursor 
solution, the formed scaffold was dried to remove DCM and then hydrated in water. 
Each scaffold was divided into four “zones” along the length of the scaffold 
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(perpendicular to the gradient) and the morphology, bioactivity, swelling and modulus of 
each zone assessed. 
4.3. Materials and Methods 
4.3.1. Materials 
 
Pt-divinyltetramethyldisiloxane complex (Karstedt‟s catalyst, 2 wt% in xylene), 
tetrakis(dimethylsiloxy)silane (tetra-SiH), and octamethylcyclotetrasiloxane (D4) were 
obtained from Gelest. Allyl methacrylate, acryloyl chloride, triflic acid, 2,2-dimethyl-2-
phenyl-acetophenone (DMPA), 1-vinyl-2-pyrrolidinone (NVP), triethylamine (Et3N), 
MgSO4, K2CO3, hexamethyldisilazane (HMDS), N3013 Nile Red (Nile Blue A 
Oxazone), NaOH, and solvents were obtained from Sigma Aldrich. HPLC grade toluene, 
CH2Cl2 (i.e. DCM) and NMR grade CDCl3 were dried over 4Å molecular sieves. 
Poly(ethylene glycol) (PEG) [PEG-6000; MW = 5000-7000 g/mol and PEG-3400; MW 
= 3000-3700 g/mol per manufacturer‟s specifications] were obtained from Sigma 
Aldrich. The Mn of PEG-3400 (3371 g/mol) and PEG-6000 (6072 g/mol) were back-
calculated from 1H NMR end-group analysis of the corresponding diacrylated products. 
Phosphate buffered solution (PBS, pH = 7.4, without calcium and magnesium) was 
obtained from Mediatech.  
4.3.2. PDMSstar-MA Synthesis 
PDMSstar-MA (1.8k, 7k and 14k g/mol) were prepared as previously reported 
[209, 210]. 
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4.3.3. PEG-DA (3.4k and 6k g/mol) Synthesis 
PEG-DA (3.4k and 6k g/mol) were prepared as previously reported [101]. By 1H 
NMR end-group analysis, Mn of PEG-DA, Mn of PEG-DA (3.4k g/mol) and PEG-DA 
(6k g/mol was determined to be 3382 g/mol (~3400 g/mol) and 5989 g/mol (∼6000 
g/mol), respectively. 
4.3.4. NMR 
1H NMR spectra were obtained on a Mercury 300 300 MHz spectrometer 
operating in the Fourier transform mode. Five percent (w/v) CDCl3 solutions were used 
to obtain spectra. Residual CHCl3 served as an internal standard.   
4.3.5. Continuous Gradient Hydrogel Scaffold Preparation  
Macromer(s) and photocatalyst solution were combined with DI-H2O or DCM 
and added to the stock and mixing chambers (the latter containing a stir bar) of a plastic 
gradient maker (Hoefer SG 15, Amersham Biosciences) or analogous glass gradient 
maker, respectively, atop a stir plate. The gradient maker output was pumped through 
PVC tubing (DI-H2O-based precursor solution) or PharMed® BPT (Ryan Herco Flow 
Solutions) (DCM-based precursor solution) tubing at ~1 mL/min via a peristaltic pump 
(C.B.S. Scientific) into a single entry top-filling vertical mold (8 cm x 6 cm x 3 mm) 
comprised of two clamped rectangular glass slides and a U-shaped Teflon spacer. The 
filled mold was immediately exposed to UV light (UV-Transilluminator, 6 mW/cm2, 365 
nm) for 3 min per side. The water-based hydrogel sheets were rinsed with DI-H2O and 
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soaked in a Petri dish containing DI-H2O (60 mL) for 2 days with daily water changes. 
The DCM-based sheets were rinsed with DCM, air dried for 30 min and placed in a Petri 
dish containing DI-H2O (60 mL). During the first hour of soaking, the water was 
changed every 15 min and thereafter daily for 2 days. All hydrogels were permitted to 
soak in DI-H2O for a total of 72 hr prior to testing. Approximately 2 mm was removed 
from the perimeter to avoid any edge irregularities. 
4.3.6. Confocal Laser Scanning Microscopy (CLSM)  
An intact zone was soaked in 60 mL of a Nile Red solution for 24 hr and then 60 
mL PBS for 3 days with daily water changes [211]. The Nile Red solution was prepared 
as follows: 75 μL of a Nile Red solution (20 mg per mL of methanol) was dissolved in 8 
mL of DI-H2O and combined with 120 mL of PBS. An 8 mm disc was punched from 
each zone along the strip, placed on a glass microscope slide and DI-H2O dropped onto 
the disk to maintain hydration. Images were captured with a Leica TCS SP5 confocal 
microscope (Leica Microsystems, Bannockburn, IL; excitation filter of 488 nm and 
emission filter 490-570 nm). Images were obtained from 3 mm sections in the z-
directions and assigned green for contrast. 
4.3.7. Scanning Electron Microscopy (SEM)  
Water-swollen hydrogels discs (8 mm diameter) were flash frozen in liquid 
nitrogen for 1 min and immediately lyophilized for 24 hr (Labconco Centri Vap Gel 
Dryer System). Specimens cross-sections were subjected to Pt-sputter coating and 
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viewed with a field emission scanning electron microscope (FEI Quanta 600 FE-SEM) 
at an accelerated electron energy of 10 keV.  
4.3.8. Swelling Ratio  
Five 8 mm discs from a given zone of five replicate hydrogel sheets were 
individually placed in a sealed vial containing 20 mL DI water and placed on a rocker 
table (250 rpm) for 48 hr at room temperature (RT).  Discs were then removed, blotted 
with filter paper, and weighed (Ws). Equilibrium swelling ratio (SR) is defined as: SR = 
(Ws - Wd)/Wd, where Ws is the weight of the water-swollen hydrogel and Wd is the 
weight of the vacuum dried hydrogel (30 in. Hg, 60 ºC, 24 hr). The average value was 
calculated from the value of three individual discs representing median values. 
4.3.9. Dynamic Mechanical Analysis (DMA) 
Five 8 mm discs from a given zone of five replicate hydrogel sheets were 
collected. Their storage modulus (G‟) was measured in the compression mode with a 
dynamic mechanical analyzer (TA Instruments Q800) equipped with parallel-plate 
compression clamp with a diameter of 40 mm (bottom) and 15 mm (top). A water-
swollen disc (8 mm diameter) was blotted with a Kim Wipe, clamped between the plates 
and silicone oil placed around the exposed hydrogel edge to prevent dehydration. 
Following equilibration at 25 °C (5 min), the samples were tested in a multi-frequency-
strain mode (1 to 30 Hz). The average value was calculated from the value of three 
individual discs representing median values. 
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4.3.10. Bioactivity  
An 8 mm disc from each zone was placed in a sealed centrifuge tube containing 
20 mL of 1X SBF[186] for 14 days at 37 C. The disc was then removed, blotted with a 
Kim Wipe and allowed to air dry for at least 24 hr.  Next, the discs were flash frozen in 
liquid nitrogen (1 min) and immediately lyophilized (24 hr) (Labconco Centri Vap Gel 
Dryer System). To view HAp, specimen surfaces were subjected to Pt-sputter coating 
and viewed with a field emission scanning electron microscope (FEI Quanta 600 FE-
SEM) at an accelerated electron energy of 10 keV.   
4.3.11. X-ray Diffraction (XRD) Spectroscopy  
Powder X-ray diffraction data was collected on a Bruker D8 diffractometer fitted 
with LynxEYE detector (Cu Kα; 40 kV, 40 mA; Bragg-Brentano geometry; scan range: 5 
- 70; step size: 0.05; step time: 1 s). 
4.4. Results and Discussion 
4.4.1. PDMSstar:PEG Gradient 
For the “PDMSstar:PEG gradient”, the scaffolds were formed with a gradual 
transition from high (top) to low (bottom) amounts of inorganic, hydrophobic PDMSstar-
MA using both DI-H2O and DCM as the fabrication solvent (Figure 4.1.a, Figure 4.2). 
The total macromer concentration (10 wt%) and Mn of both PDMSstar-MA (7k g/mol) 
and PEG-DA (3.4k g/mol) were held constant. Two different precursor solutions were 
prepared with different wt% ratios of PDMSstar-MA to PEG-DA: 0:100 (mixing 
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solution) and 20:80 (stock solution). For every one mL of precursor solution was added 
10 L of photoinitiator solution (30 wt% solution of DMPA in NVP). The solutions 
were vortexed for 1 minute following addition of each component, poured into their 
respective chambers and the gradient hydrogel fabricated as stated above.  
CLSM images confirmed the transition in PDMSstar-MA concentration among 
the different zones of the gradient (Figure 2.a and 2.e). Consistent with that previously 
observed for single composition scaffolds (i.e. “non-gradients” not formed with a 
gradient maker), the PDMSstar-MA formed discrete microspheres or was uniformly 
distributed when prepared from an DI-H2O[127] or DCM[100] precursor solution, 
respectively. This was attributed to the improved solubility of PDMSstar-MA in DCM 
versus in DI-H2O. As also previously noted with non-gradient scaffolds,[100] gradient 
scaffolds formed with a DCM precursor solution exhibited enhanced pore size, 
particularly in zones containing high levels of PDMSstar-MA. The increased pore size is 
attributed to SIPS [100, 208].  During SIPS, phase separation between the growing 
polymer network and solvent during cure leads to pore formation [37,[94, 95].  A 
macroporous morphology is generally useful due to enhanced diffusion of cellular waste 
and nutrients as well as for varying cell-cell proximity [79, 83]. Macroporous 
morphologies also contribute to an enhanced rate of degradation [36, 37, [82, 84]. In 
fact, faster rates of degradation were observed for non-gradient macroporous PDMSstar-
PEG hydrogels (i.e. prepared from a DCM precursor solution) versus the analogous 
hydrogel prepared from an aqueous precursor solution [100]. It has also previously noted 
that non-gradient PDMSstar:PEG hydrogels exhibited both bioactivity[100] as well as 
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osteoinductivity [108]. Bioactive materials are attractive for bone regeneration as they 
chemically bond to adjacent native bone tissue via formation of a biologically active 
hydroxyapatite (HAp) layer [190]. Furthermore, the formation of HAp has also been 
shown to promote differentiation of mesenchymal stem cells (MSCs) to osteoblasts 
[191]. It was observed that non-gradient PDMSstar-PEG hydrogels increased stimulation 
of osteogenic differentiation of encapsulated MSCs in proportion to PDMSstar-MA 
content [108]. This behavior was attributed to the inorganic, hydrophobic nature of 
PDMSstar-MA, features commonly associated with other bioactive materials [105-107]. 
Thus, gradient scaffolds with a gradual change in bioactivity would be exceptionally 
useful, not only to screen cell-material interactions, but also for the ultimate regeneration 
of native-like osteochondral tissues which possess a gradual transition from osseous to 
cartilage tissue. The variation in bioactivity along the gradient scaffold was assessed via 
immersion in simulated body fluid (SBF, 1X) for two weeks followed by observing the 
amount of HAp formed via SEM. This protocol is considered to be a qualitative 
indication of the level of scaffold bioactivity and has also been correlated to the ability to 
bond to bone in vivo [192]. Indeed, it was found that the level of HAp gradually 
increased with the content of PDMSstar-MA along the gradient (Figure 4.2.b and 4.2.f). 
X-ray diffraction (XRD) was used to verify that the mineral deposits were HAp. Two 
zones exhibiting HAp with contrasting morphologies were examined (Figure 4.3). 
Characteristic HAp peaks of 31.7, 45.5, and 56.5 were noted. These peaks indicate 
reflections from 112, 222, 004 crystal planes respectively and correspond to Bragg 
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reflections of Hap [212]. The decreased amplitude of the peak at 31.7 for scaffold could 
be a result of the inhomogeneity of the HAp on the surface.  
Given the known impact of swelling (i.e. hydration)[67] and modulus (i.e. 
stiffness)[86, 87, 140] on cell behavior, these properties were also assessed among the 
different zones of the gradient scaffolds (Figure 4.2.c and 4.2.d). For the gradient 
scaffold fabricated via SIPS, swelling increased (~5.5 to 6.8) and modulus decreased 
(~400 to 325 kPa) as the level of hydrophobic PDMSstar-MA decreased. In contrast, 
since PDMSstar-MA formed discrete microspheres in an “unperturbed” PEG matrix when 
fabricated in DI-H2O,[101] resulting in swelling that remained very consistent (~8.6 to 
8.9) across the entire gradient while modulus decreased modestly (~110 to 80 kPa). In 
this way, swelling and modulus are uniquely decoupled such that the effect of each 
parameter on cell behavior may be studied independent of one another. Notably, 
modulus was substantially higher for the gradient scaffold fabricated in DCM versus in 
DI-H2O. As noted previously, the enhanced modulus may be due to the decreased 
hydration arising from a more homogeneous distribution of hydrophobic PDMSstar-MA 
as well as well as the increased pore size and hence pore wall thickness when fabricated 
via SIPS [213, 214]. For most zones, the SIPS gradient exhibits a substantial change in 
modulus (and hydration) within the range that has been shown to impact cell behavior 
[86, 215-217]. In contrast, the gradient fabricated in DI-H2O exhibited seemingly minor 
zone-to-zone changes in modulus and hydration. This may afford the opportunity to 
decouple the effect of swelling and modulus from, for instance, PDMS content on cell 
behavior.  
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Figure 4.2. Properties of PDMSstar:PEG gradient scaffolds. These scaffolds (depicted in Figure 4.1.a) were 
formed with a gradual transition from high (top) to low (bottom) amounts of PDMSstar-MA using both DI-
H2O and DCM as the fabrication solvent. The total macromer concentration (10 wt%) and Mn of both 
PDMSstar-MA (7k g/mol) and PEG-DA (3.4k g/mol) were held constant. For gradient scaffolds prepared from 
an aqueous and DCM precursor solution, respectively: (a, e) CLSM images of PDMSstar-MA distribution and 
scaffold porosity, (b, f) SEM images of HAp formation following exposure to SBF (i.e. “bioactivity”) and (c, 
d) swelling and modulus. 
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4.4.2. Total Wt% Macromer Concentration Gradient 
For the “total wt% macromer concentration gradient”, scaffolds were formed 
with a gradual transition in the total wt% of macromer from low (top) to high (bottom) 
with a constant 9:91 wt% ratio of PDMSstar-MA (7k g/mol) to PEG-DA (3.4k g/mol) 
(Figure 4.1.b, Figure 4.4). Two precursor solutions were prepared at two different 
concentrations: 20 wt% (mixing solution) and 5 wt% (stock solution). First, 20 wt% 
PEG-DA (mixing solution) and 5 wt% PEG-DA (stock solution) were each dissolved in 
DCM or DI-H2O and the appropriate amount of PDMSstar-MA was added to achieve a 
9:91 wt% ratio. This wt% ratio was selected as it represents an intermediate wt% ratio as 
was utilized the “PDMSstar:PEG gradients”. Formation of the gradient scaffolds 
proceeded as noted above. However, for gradients fabricated from a DCM precursor 
solution, the mold was exposed to UV light while it was filled. This was done after 
Figure 4.3. Right: SEM of HAp formation on (a) PDMSstar:PEG gradient (fabricated in DI-H2O); zone 
1 and (b) PEG-DA Mn gradient (fabricated in DI-H2O); zone 4. Left: XRD of “a” and “b” exhibit 
characteristic HAp peaks of 31.7, 45.5, and 56.5. 
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observing that scaffolds exposed to UV light only after the mold was filled did not 
maintain the wt% gradient, perhaps due to substantial interdiffusion of these particular 
solutions. After filling, the mold continued to be exposed to UV light for an additional 6 
min. 
CLSM imaging visually confirmed constant levels of PDMSstar-MA along the 
gradient but with the same distribution features based on precursor solution solvent as 
per the PDMSstar:PEG gradient scaffolds (Figures 4.4.a and 4.4.e). For the scaffold 
gradient made from a DCM precursor solution, pore size generally increased with wt% 
macromer concentration due to an enhanced SIPS process. The constant levels of 
PDMSstar-MA produced similar levels of HAp formation along the gradient (Figures 
4.4.b and 4.4.f).  
 For gradient scaffolds prepared in DI-H2O, the increase in total wt% of 
macromer led to an expected dramatic decrease in swelling ratio (~12 to 5.6) (Figure 
4.4.c).  This was the widest range of swelling ratio values observed for a given scaffold 
composition. The substantial decrease in swelling was accompanied by a considerable 
increase in modulus values (~90 to 280 kPa). In contrast, swelling ratios were very 
similar (~5.8) among zones of the gradient scaffold fabricated with DCM (Figure 4.4.d). 
This may be attributed to the larger pore size that accompanied the increased wt% 
macromer concentration. Modulus values were distributed over a narrow range (~290 to 
350 kPa). Thus, this latter gradient has utility for screening the impact of pore size 
uncoupled from both hydration and modulus. 
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4.4.3. PEG-DA Mn Gradient 
For the “PEG-DA Mn gradient”, scaffolds were formed with a gradual transition 
in the PEG-DA Mn from low (top) to high (bottom) with a constant 9:91 wt% ratio of 
PDMSstar-MA (7k g/mol) to PEG-DA (Figure 4.1.c, Figure 4.5). In this way, the 
crosslink density of the scaffold varies from high (top) to low (bottom). Two precursor 
solutions were prepared with two different Mn(s) of PEG-DA: 6k g/mol (mixing 
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Figure 4.4. Properties of total wt% macromer concentration gradient scaffolds. These scaffolds (depicted 
in Figure 4.1.b) were produced with a gradual transition from low (top) to high (bottom) total wt% 
macromer concentrations. A constant 9:91 wt% ratio of PDMSstar-MA (7k g/mol) to PEG-DA (3.4k g/mol) 
was maintained. For gradient scaffolds prepared from an aqueous and DCM precursor solution, 
respectively: (a, e) CLSM images of PDMSstar-MA distribution and scaffold porosity, (b, f) SEM images 
of HAp formation following exposure to SBF (i.e. “bioactivity”) and (c, d) swelling and modulus 
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solution) and 3.4k g/mol (stock solution). Both solutions were prepared at a constant 
concentration of 10 wt% PEG-DA in either DCM or DI-H2O and the appropriate amount 
of PDMSstar-MA added to achieve a 9:91 wt% ratio (PDMSstar-MA to PEG-DA). 
Formation of the gradient scaffolds proceeded as noted above.  
CLSM imaging visually confirmed constant levels of PDMSstar-MA along the 
gradient but with the same distribution features based on precursor solution solvent as 
noted above (Figures 4.5.a and 4.5.e). For the scaffold gradient made from a DCM 
precursor solution, higher PEG-DA Mn produced a somewhat higher concentration of 
pores and larger pore sizes. Similar levels of HAp formed along the gradient were 
observed due to the constant levels of PDMSstar-MA (Figures 4.5.b and 45.f).  
Because of the corresponding decrease in crosslink density, an increase in  
PEG-DA Mn resulted in an increase in swelling and a decrease in modulus (Figures 
4.5.c and 4.5.d). For gradient scaffolds prepared in DI-H2O, the swelling ratio varied 
moderately (~8.4 to 9.6) and produced a likewise moderate decrease in modulus (~105 
to 75 kPa).  Scaffolds fabricated in DCM produced a wider range of swelling ratios (~6.6 
to 8.3) as well as modulus values (~205 to 130 kPa).  
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4.4.4. PDMSstar-MA Mn Gradient 
For the “PDMSstar-MA Mn gradient”, scaffolds were formed with a gradual 
transition in PDMSstar-MA Mn from low (top) to high (bottom) with a constant 9:91 wt% 
ratio of PDMSstar-MA to PEG-DA (3.4k g/mol) (Figure 4.1.d, Figure 4.6). Two 
precursor solutions were prepared with two different Mn‟s of PDMSstar-MA: 14k g/mol 
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Figure 4.5. Properties of PEG-DA Mn gradient scaffolds. These scaffolds (depicted in Figure 4.1.c) were 
produced with a gradual transition from low (3.4k g/mol) (top) to high (6k g/mol) (bottom) PEG-DA Mn with 
a constant 9:91 wt% ratio of PDMSstar-MA (7k g/mol) to PEG-DA. For gradient scaffolds prepared from an 
aqueous and DCM precursor solution, respectively: (a, e) CLSM images of PDMSstar-MA distribution and 
scaffold porosity, (b, f) SEM images of HAp formation following exposure to SBF (i.e. “bioactivity”) and (c, 
d) swelling and modulus. 
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(mixing solution) and 1.8k g/mol (stock solution). Both solutions were prepared at a 
constant concentration of 10 wt% PEG-DA in either DCM or DI-H2O and the 
appropriate amount of PDMSstar-MA added to achieve a 9:91 wt% ratio (PDMSstar-MA 
to PEG-DA). Thus, in contrast to the “PEG-DA Mn gradient”, here, the Mn of the minor 
component (PDMSstar-MA) is varied. Formation of the gradient scaffolds proceeded as 
noted above.  
When DI-H2O was used as the fabrication solvent, CLSM images showed 
increased PDMSstar-MA Mn enhanced its insolubility in water and led to an increase in 
PDMS-microparticle number and size (Figures 4.6.a). When DCM was used as the 
fabrication solvent, the increase in PDMSstar-MA Mn enhanced the effects of SIPS, 
leading to the general increase in pore size (Figures 4.6.e).  For both gradient scaffolds, 
HAp was observed in all zones due to the constant level of PDMSstar-MA (Figures 4.6.b 
and 4.6.f).  
For both gradient scaffolds, swelling ratio was quite constant and modulus 
remained varied within a tight range across the different zones (Figures 4.6.c and 
4.6.d). Again, this is expected since it was the Mn of the minor component (PDMSstar-
MA) that was continuously varied. However, the fabrication solvent had a notable 
impact on these properties. When prepared from an aqueous precursor solution, swelling 
and modulus (~10 and ~65 to 40 kPa) were substantially higher and lower, respectively, 
versus the gradient scaffolds prepared from DCM precursor solution (~7 and ~205 to 
175 kPa). Thus, these scaffolds would permit the evaluation of subtle changes in scaffold 
modulus independent of hydration.  
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 4.5. Conclusions 
Herein, “hybrid” continuous gradient hydrogel scaffolds have been prepared 
based on combining an inorganic (PDMSstar-MA) and organic macromer (PEG-DA) and 
using both aqueous and organic fabrication solvents. The previously established 
bioactivity[100] and osteoinductivity[108] of PDMSstar-MA makes it a particularly 
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Figure 4.6. Properties of PDMSstar-MA Mn gradient scaffolds. These scaffolds (depicted in Figure 4.1.d) 
were produced with a gradual transition from low (top) to high (bottom) PDMSstar-MA Mn with a 
constant 9:91 wt% ratio of PDMSstar-MA to PEG-DA  (3.4k g/mol). For gradient scaffolds prepared from 
an aqueous and DCM precursor solution, respectively: (a, e) CLSM images of PDMSstar-MA distribution 
and scaffold porosity, (b, f) SEM images of HAp formation following exposure to SBF (i.e. 
“bioactivity”) and (c, d) swelling and modulus. 
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powerful component to incorporate into gradient scaffolds based on PEG-DA. These 
scaffolds were quickly produced and exhibited spatially varied chemical and physical 
properties. Specifically, the ability to spatially control PDMSstar-MA distribution, pore 
size, bioactivity, swelling and modulus within a single scaffold was demonstrated. The 
eight gradient scaffolds reported herein exhibited swelling values from ~5.5 to 12 and 
modulus values from ~40 to 405 kPa. Their rapid production and achievable range of 
properties not only allow for rapid screening of cell-material interactions, but would also 
prove useful towards the regeneration of interfacial tissues which require scaffolds 
comprised of spatially organized material compositions [114, 115]. Given the bioactivity 
and osteoinductivity of PDMSstar-MA, these hybrid scaffolds are particularly of interest 
for bone and osteochondral tissue engineering. In the case of hydrogel gradients 
produced via SIPS, direct photoencapsulation obviously is prohibited.  Thus, pore 
interconnectivity, essential for 3D penetration of seeded cells will require modification 
of fabrication with a poragen strategy (e.g. salt leaching). 
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CHAPTER V  
SYNTHESIS OF AMINATED AND PHOSPHONATED POLY(DIMETHYL 
SILOXANE) METHACRYLATE FOR ENHANCED BIOACTIVITY AND 
OSTEOINDUCTIVITY 
5.1. Introduction 
Similar to the extracellular matrix (ECM) in natural tissues, properties of the 
tissue engineering scaffold direct cell behavior and accordingly tissue regeneration [131, 
132].  These include both physical properties (e.g. morphology or porosity [77, 81, 136] 
and modulus [86, 87, 140]) as well as chemical properties (e.g. chemical functionality, 
[75, 76, 105] hydrophobicity, [102, 174] hydration [87, 128, 175] and bioactivity [105, 
106]). Thus, scaffolds with properties modified for optimal cell regeneration have the 
potential to form tissues with properties closely resembling those of native tissues [1, 
201].  
In previous work, physical and chemical properties of poly(ethylene glycol) 
diacrylate (PEG-DA)-based hydrogel scaffolds were altered via both incorporation of  
methacrylated star poly(dimethyl siloxane) (PDMSstar-MA) and fabrication with solvent-
induced phase separation (SIPS) [100, 208]. SIPS produced hydrogels with low sol 
contents and low cytotoxicity as well as increased pore size, enhanced modulus and a 
more uniform distribution of PDMSstar-MA versus analogous hydrogels fabricated from 
aqueous precursor solutions. In addition, PDMSstar-PEG hydrogels fabricated from 
aqueous precursor solutions were bioactive, forming hydroxyapatite when exposed to 
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simulated body fluid (SBF) [100] and furthermore resulted in an increase in osteogenic 
differentiation of encapsulated mesenchymal stem cells (MSCs) corresponding to 
PDMSstar-MA content [108]. This is ideal as bioactive, osteoinductive scaffolds improve 
regeneration of and integration into bone tissue [218].  
The focus of this study is further enhancement of the bioactivity and 
osteoinductivity of a PDMS macromer via functionalization with amine and 
phosphonate groups. Well-defined (2D) models have been used to study the effects of 
amine and phosphonate on cell behavior [116-119]. Keselowsky et al. demonstrated that 
surfaces grafted with amine groups up-regulated osteoblast-specific gene expression, 
alkaline phosphatase enzymatic activity, and matrix mineralization [117]. The positive 
charge on these functional groups at neutral pH may explain this phenomenon [117]. 
Increasing phosphonate content of graft copolymers on the surfaces of biomaterials 
increased osteoblast-like cell adhesion and proliferation [120]. Also, the 
functionalization of polymers with phosphorous-containing pendant groups has shown to 
result in more complete mineralization and at a faster rate [121]. Recent findings suggest 
phosphate-containing polymers possess an affinity for calcium ions necessary for the 
development of biomaterial-associated calcification [219, 220]. Thus, it was expected 
that amine and phosphonate functionalized PDMS would exhibit enhanced bioactivity 
and osteoinductivity.  
Phosphorous-based scaffolds are of particular interest for bone tissue 
regeneration given the ideal osteoinductive environment they are able to provide [123-
125]. Saltzman et al. found that the adhesion and growth of osteoblast-like cells within 
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acrylamide gels increased with increasing phosphonate content [123]. While, Anseth et 
al. incorporated pendant phosphate groups into PEG hydrogels and saw an increased rate 
and degree of mineralization within the hydrogel even in the absence of hMSCs [126]. 
Amines have not been incorporated into hydrogel scaffolds for cell behavior studies with 
regard to osteoinductivity and bioactivity, providing further motivation for the study 
herein. 
In this work, amine functionalized PDMS has been synthesized. Also, a protocol 
and rationale for further functionalization with phosphonate has been established 
(Figure 5.1). Based on the osteoinductivity and bioactivity of PDMS [99, 108] it is 
expected that amine and phosphonate groups would further enhance these properties. 
Future methacrylation and incorporation of these macromers into the previously 
described PEG-DA scaffold system is expected to provide a method of study regarding 
their effects on cell behavior in a 3D environment. These scaffolds are also anticipated to 
be valuable for osteochondral tissue regeneration. 
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5.2. Materials and Methods 
5.2.1. Materials 
Heptamethyl-cyclotetrasiloxane (D4
H1), 1,1,3,3,5,5,7,7,9,9-decamethylpenta-
siloxane, 95% (DMPS), and tetramethylammonium siloxanolate (TMAS) were obtained 
from Gelest. Activated carbon was obtained from Fisher Scientific. Platinum (IV) oxide 
(PtO2), allyl amine, and NMR grade CDCl3 were obtained from Sigma Aldrich. CDCl3 
was dried over 4Å molecular sieves.  
Figure 5.1.  Amine and phosphonate functionalized PDMS-MA described herein for subsequent 
incorporation into PEG-DA hydrogels towards enhanced bioactivity and osteoinductivity of tissue 
engineering scaffolds. 
Methacrylated Poly(D4
NH2)
Methacrylated Poly(D4
P)
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5.2.2. Aminotrimethyleneheptamethylcyclo-tetrasiloxane (D4
NH2
) Synthesis (Figure 
5.2.a) 
D4
NH2 was prepared as previously reported [221]. Briefly, D4
H1 (5.1 g, 18 mmol), 
allyl amine (1.55 g, 27 mmol) and a small amount of PtO2 were added in a pressure 
vessel under nitrogen. The vessel was sealed and heated at 85°C for 24 h. The product 
was then removed, allowed to cool, and analyzed with NMR. In the case of incomplete 
reaction, additional allyl amine and PtO2 was added, the reaction purged with nitrogen, 
and allowed to proceed at 85°C for 4 h. After cooling to room temperature, the crude 
product was combined with two identical reactions to improve yield, and activated 
carbon added. The reaction was then purified by vacuum distillation and vacuum dried at 
60 ºC overnight to afford product D4
NH2 (11g, yield 56%, bp: 78°C/0.8 mm Hg). 1H-
NMR (δ ppm): 2.65–2.61 (m, 2H, NH2–CH2–CH2–CH2), 1.49–1.39 (m, 2H, NH2–CH2–
CH2–CH2), 0.51–0.46 (m, 2H, NH2– CH2–CH2–CH2), 0.04 (s, 21H, Si–CH3). 
5.2.3. Amine Functionalized Poly(dimethyl siloxane) (Poly (D4
NH2
)) Synthesis (Figure 
5.2.b) 
D4
NH2 (2.75 g, 8.1 mmol), DMPS 0.23 g (0.63 mmol) and TMAS (0.1 wt %) were 
combined in a round bottom flask equipped with a magnetic stir bar and rubber septum. 
The air in the flask was exchanged with nitrogen and the reaction temperature increased 
to 90°C. After 10 h, the reaction was heated at 140 ºC for 3 h while bubbling nitrogen 
through to decompose the catalyst. The reaction mixture was then heated at 125 ºC under 
vacuum for 5 h to remove cyclics [222]. Colorless oil was given (1.7 g, yield 57%). 
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1HNMR (δ ppm): 2.66–2.61 (m, 32H, NH2–CH2–CH2– CH2), 1.49–1.39 (m, 32H, NH2–
CH2–CH2–CH2), 0.52– 0.46 (m, 32H, NH2–CH2–CH2–CH2), 0.05 (s, 431H, Si–CH3); Mn 
(g/mol): 5700. 
 
 
 
 
 
 
 
 
 
 
 
5.2.4. NMR 
 
1H NMR spectra were obtained on a Mercury 300 300 MHz spectrometer 
operating in the Fourier transform mode. Five percent (w/v) CDCl3 solutions were used 
to obtain spectra. Residual CHCl3 served as an internal standard.  
Figure 5.2.  (a) Platinum catalyzed hydrosilylation of D4
H1 with allyl amine to yield 
D4
NH2 and (b) base catalyzed ring opening polymerization of D4
NH2 to yield silane 
terminated, amine functionalized PDMS (Poly(D4
NH2)). 
+
PtO2
85 C, 24hrs
TMAS,90 C,10hrs
D4
NH2
DMPS
Poly(D4
NH2)
D4
H1
Allyl
Amine
a
b
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5.3. Results and Discussion  
Materials which promote mineralization can be incorporated into tissue 
engineering scaffolds for improved regeneration of bone tissue [218]. The bioactivity of  
PDMS, [100, 109] phosphonates, [116, 125] and amines [117, 118] has been established. 
Thus, it was expected that PDMS functionalized with amine and phosphonate would 
result in significantly enhanced bioactivity and osteoinductivity. Therefore, a 
straightforward synthesis for the functionalization of PDMS with either amine (Figures 
5.2 and 6.2) or phosphonate (Figures 5.2 and 6.3) has been described herein. A linear 
PDMS polymer has been synthesized as a more complex synthesis is required compared 
to previous studies involving PDMSstar-MA. Linear PDMS will provide a more 
simplistic approach for analysis of these novel polymers.  
5.3.1. Amine Functionalized Poly(dimethyl siloxane) (Poly (D4
NH2
)) Synthesis  
Functionalization of PDMS with amine (Poly (D4
NH2)) is a two-step synthesis 
(Figure 5.2). First, a siloxane ring possessing one functional silane underwent 
hydrosilylation with the vinyl of allyl amine (Figure 5.2.a). The product was black due 
to the use of a platinum catalyst. The catalyst was subsequently removed by distilling 
with activated carbon, yielding a clear product. Thorough removal of the catalyst is 
expected to be important for subsequent synthesis.  
Next, the siloxane ring was opened using a base catalyzed ring opening 
polymerization with a short silane terminated dimethylsiloxane as an end capping agent 
(Figure 5.2.b). This resulted in a silane terminated, amine functionalized PDMS 
 92 
 
polymer. The polymer is such that every third siloxane repeat unit possesses a functional 
amine (assuming complete reaction). The molecular weight of the polymer synthesized 
herein was determined to be 5700 g/mol by end-group analysis This gives an “x” value 
of 16 (Figure 5.2.b). Molecular weight may be increased or decreased with longer and 
shorter reaction times, respectively. The silane groups on each end of the PDMS will 
allow for the subsequent hydrosilylation with allyl methacrylate thereby permitting 
subsequent photo-crosslinking with PEG-DA (Figures 6.1 and 6.2).  NMR spectroscopy 
was used to confirm each synthetic step as well as determine molecular weight of the 
polymer.  
 
5.3.2. Phosphonate Functionalized Poly(dimethyl siloxane)  (Poly(D4
P
)) Proposed 
Synthesis  
The synthesis of phosphonate functionalized PDMS (Poly(D4
P)) began in the 
same way as that of Poly(D4
NH2) (Figure 5.2). However, an additional subsequent step is 
required to attach the phosphonate. This can be done by reacting the vinyl group of 
DEVP with the functional amine on Poly(D4
NH2) via an aza-Michael Addition (Figure 
6.3.a). Similar to the synthesis of Poly(D4
NH2), the silane side groups can then be reacted 
with allyl methacrylate to introduce photo-crosslinking capabilities (Figure 6.3.b).  
5.4. Conclusions 
Herein, the synthesis of amine functionalized poly(dimethyl siloxane) was 
reported (Figure 5.2). In addition, a protocol for phosphonate functionalized PDMS was 
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established (Figures 5.2 and 6.3.a). Based on the previously established bioactivity of 
PDMS, [100, 109] phosphonates, [116, 125] and amines [117, 118] it is  expected that 
these hybrid materials will exhibit significant bioactivity and osteoinductivity.  
Future addition of methacrylate end groups will allow incorporation into 
hydrogel scaffolds. This is expected to deliver a tissue engineering scaffold capable of 
regenerating more native-like bone tissue. It is expected that these novel macromers 
combined with previously described fabrication processes (i.e. SIPS and continuous 
gradients) will provide a platform for the rapid assessment of a broad range of 
properties. These studies are anticipated to result in the establishment of an ideal 
environment for bone, cartilage, and bone – cartilage interfacial tissue regeneration.  
 
 
 
  
 
 
 94 
 
CHAPTER VI  
CONCLUSIONS AND FUTURE DIRECTIONS 
6.1. Conclusions 
Herein, “hybrid” continuous gradient hydrogel scaffolds have been prepared 
based on combining an inorganic and organic macromer and using both aqueous and 
organic fabrication solvents. This research resulted in the establishment of a “library” of 
3D scaffolds useful for both the study of cell-material interactions as well as interfacial 
tissue regeneration.  
In Chapter II, the ability to greatly enhance and alter the physical properties of 
PEG-DA hydrogels based solely on varying fabrication solvent was demonstrated [93]. 
The SIPS fabrication process produced hydrogels with macroporous morphologies and 
increased modulus values versus analogous PEG-DA hydrogels fabricated from an 
aqueous precursor solution. Particularly, certain properties were uncoupled, such as 
morphology and hydration or modulus and hydration such that their impact on cell 
behavior may be isolated.  In addition, PEG-DA hydrogels prepared via SIPS exhibited 
enhanced degradation rates.  In total, these SIPS PEG-DA hydrogel scaffolds possess 
properties beneficial for tissue engineering applications and cell-material interaction 
studies.  
In Chapter III, modification of hydrogel chemistry and bioactivity of the scaffold 
was explored via incorporation of inorganic, hydrophobic PDMSstar-MA into PEG-DA 
hydrogels [100]. When fabricated via SIPS (rather than with an aqueous precursor 
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solution), the enhanced solubility of PDMSstar-MA resulted in a more homogenous 
distribution. In addition, modulus and pore size were increased. Bioactivity was 
confirmed with in vitro assessment of HAp formation on the scaffolds in the presence of 
SBF. Thus, it was expected that these scaffolds would specifically enhance outcomes for 
bone tissue regeneration. Also, the unique combination of properties presented by 
PDMSstar-PEG hydrogels formed by SIPS renders them useful to study both physical and 
chemical properties-guided cell behavior.  
In Chapter IV, continuous gradient scaffolds were prepared to spatially control 
PDMSstar-MA distribution, pore size, bioactivity, swelling and modulus within a single 
PEG-DA hydrogel scaffold [109]. The rapid production and broad range of properties 
would permit prompt screening of cell-material interactions. Furthermore, with 
controlled distribution of bioactive PDMSstar-MA, these hybrid scaffolds are of 
particular interest for bone and osteochondral tissue engineering [114, 115].  
Chapter V is focused on enhancing the bioactivity and osteoinductivity of 
PDMS-MA by incorporating amine and phosphonate functional groups. Both of these 
functional groups have shown the ability to promote mineralization and osteoblast 
differentiation [116, 117]. Thus, PDMS polymer was functionalized with an amine (Poly 
(D4
NH2)). Also, motivation for and a synthetic approach towards further functionality of 
Poly(D4
NH2) with phosphonate was given. The subsequent attachment of cross-linkable 
side groups will allow for the incorporation of these polymers into a hydrogel scaffold. 
Such macromers can be used in systems like those of Chapters III and IV to further 
modify and enhance PEG-DA scaffold properties.  
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6.2. Future Directions 
6.2.1. Poly(D4
NH2
) and Poly(D4
P
) – PEG-DA Hydrogel Scaffolds  
Future studies will combine the synthetic and fabrication techniques described in 
the preceding chapters to create a library of scaffolds based on the incorporation of 
Poly(D4
NH2) and Poly(D4
P) into PEG-DA hydrogel scaffolds. Similarly to the methods 
described in Chapter IV, these functionalized polymers can be incorporated into PEG-
DA scaffolds along a continuous gradient (Figure 6.1). This will allow for the rapid 
screening of cell-material interactions. It is also expected that this will provide an 
improved scaffold for the regeneration of osteochondral tissue due to the additional 
bioactivity of the amine and phosphonate moieties on bioactive, osteoinductive PDMS.  
The use of both DCM and DI-H2O is expected to further alter the properties (e.g. 
porosity, stiffness, and hydration) based on the combination of phosphonate and amine 
with hydrophobic PDMS.  
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6.2.1.1. Methacryalted Poly(D4
NH2
) and Methacryalted Poly(D4
P
)  Synthesis 
The synthesis from Chapter V will be completed in future studies yielding two 
bioactive polymers capable of crosslinking within a hydrogel scaffold (Figure 6.1). 
First, the completion of the synthesis of Poly(D4
NH2) requires the attachment of photo-
crosslinkable end groups. The silane side groups can be reacted with the vinyl group of 
allyl methacrylate via a “Pt” catalyzed hydrosilylation reaction (Figure 6.2). When 
Figure 6.1. Methacrylated Poly(D4
NH2) and Poly(D4
P) can be subsequently incorporated into the “gradient 
platform technology” established in Chapter IV allowing for rapid screening and potentially the 
fabrication of more native-like osteochondral interface. Amine and phosphonate moieties on PDMS are 
expected to enhance properties of PEG-DA hydrogel scaffolds, including bioactivity. 
Methacrylated Poly(D4
NH2)
Methacrylated Poly(D4
P)
Gradient fabricated in H2O or DCM
PDMS-Amine
• Positively charged amine 
• Bioactive
• Altered distribution in solvents
PEG-DA
PEG
P
o
ly
(D
4
P
)
PEG
PDMS-Phosphonate
• Phosphorous is a bone mineral 
and plays a role in the 
formation of HAp
• Bioactive
• Altered distribution in solvents
P
o
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4
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H
2
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combined with a photo-catalyst, this provides a means for photo-crosslinking this 
polymer into a PEG-DA hydrogel (Figure 6.1.).   
 
 
 
 
 
 
 
 
 
The synthesis of Poly(D4
P) requires an additional step in which the phosphonate 
is attached to the amine moiety. This can be done by reacting the vinyl group of DEVP 
with the functional amine on Poly(D4
NH2) via an aza Michael Addition (Figure 6.3.a). 
Similar to the synthesis of Poly(D4
NH2), the silane terminated polymer can then be 
reacted with allyl methacrylate to introduce a mechanism for photo-crosslinking the 
polymer into a hydrogel (Figure 6.3.b). 
Figure 6.2. Hydrosilylation of D4
NH2 with allyl methacrylate to yield an amine functionalized 
polymer capable of photo-crosslinking into a PEG-DA hydrogel scaffold. 
Methacrylated Poly(D4
NH2)
Poly(D4
NH2)
Allyl Methacrylate
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 6.2.1.2. Spatially Controlled Incorporation of Poly(D4
NH2
) and Poly(D4
P
)  into 
PEG-  DA Hydrogels  
 Based on previous studies, altered scaffold properties are expected as a result of 
varied dissolution and distribution of these materials dependent on solvent polarity 
[100]. The use of solvent is also expected to alter physical properties (i.e. increased pore 
size and modulus) [93]. Utilizing the recently established gradient fabrication platform 
[109] will allow for rapid assessment of cell – material interactions. The combination 
and spatial control of properties such as bioactivity (e.g. mineral deposition), modulus, 
porosity, and hydrophilicity is expected provide an ideal environment for osteochondral 
interface tissue regeneration. 
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DEVP
Poly(D4
P)
Allyl
Methacrylate
Methacrylated Poly(D4
P)
Poly(D4
NH2)
a
b
Figure 6.3.  (a) Platinum catalyzed hydrosilylation of Poly(D4
NH2) with DEVP to yield a 
phosphonate functionalized polymer and (b) platinum catalyzed hydrosilylation of Poly(D4
P) to yield 
a phosphonate functionalized polymer capable of photo-crosslinking within a PEG-DA hydrogel. 
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6.2.2. Enhanced Osteoconductivity and Biodegradability  
 In the case of hydrogel scaffolds produced via SIPS, direct photoencapsulation is 
obviously prohibited. Thus, to permit cell seeding resulting in full thickness delivery, the 
requisite pore interconnectivity can be achieved by incorporation of a poragen (e.g. salt 
leaching).  Grunlan et al. recently fabricated inorganic–organic shape memory polymer 
foams with tunable pore size and high interconnectivity. This was done via a refined 
solvent-casting/particulate-leaching (SCPL) method [223]. Briefly, salt particles were 
fused by the addition of water. A solution of acrylated polymer in DCM was then photo-
cured around the fused salt matrix and the salt matrix removed via leaching resulting in 
interconnected pores.  
In addition, biodegradation of the scaffolds could be further enhanced and altered 
as the scaffold‟s degradation rate should parallel that of the regeneration of tissue. This 
can be done via substitution of PDMS with poly(silyl ether) (PSE). Due to its more 
hydrophilic nature and the hydrolytic instability of silyl ether bonds, faster degradation is 
expected. Thus, degradation rate can be altered based on the choice of macromere (i.e. 
PDMS or PSE) incorporated into the SIPS fabricated PEG-DA hydrogel.  
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6.0 5.5 5.0 4.5 4.0 3.5 PPM
1H-NMR of PEG-DA (3.4k g/mol) [From Chapters II and III] 
1H-NMR of PEG-DA (6k g/mol) [From Chapters II and III] 
6.5 6.0 5.5 5.0 4.5 4.0 3.5 PPM
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4 3 2 1 0 PPM
1H-NMR of PDMSstar-SiH (7k g/mol) [From Chapter III] 
6 5 4 3 2 1 0 PPM
1H-NMR of PDMSstar-MA (7k g/mol) [From Chapter III] 
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6.0 5.5 5.0 4.5 4.0 3.5 PPM
1H-NMR of PEG-DA (3.4k g/mol) [From Chapter IV] 
6.5 6.0 5.5 5.0 4.5 4.0 3.5 PPM
1H-NMR of PEG-DA (6k g/mol) [From Chapter IV] 
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5 4 3 2 1 0 PPM
1H-NMR of PDMSstar-SiH (1.8k g/mol) [From Chapter IV] 
1H-NMR of PDMSstar-MA (1.8k g/mol) [From Chapter IV] 
6 5 4 3 2 1 0 PPM
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4 3 2 1 0 PPM
1H-NMR of PDMSstar-SiH (7k g/mol) [From Chapter IV] 
7 6 5 4 3 2 1 0 PPM
1H-NMR of PDMSstar-MA (7k g/mol) [From Chapter IV] 
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4 3 2 1 PPM
1H-NMR of PDMSstar-SiH (14k g/mol) [From Chapter IV] 
6 5 4 3 2 1 0 PPM
1H-NMR of PDMSstar-SiH (14k g/mol) [From Chapter IV] 
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1H-NMR of D4
NH2 [From Chapter V] 
4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 PPM
4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 PPM
1H-NMR of P-D4
NH2 [From Chapter V] 
